A	O
family	O
of	O
serine	B-protein
proteases	I-protein
expressed	O
exclusively	O
in	O
myelo-	O
monocytic	B-cell_type
cells	I-cell_type
specifically	O
processes	O
the	O
nuclear	B-protein
factor-kappa	I-protein
B	I-protein
subunit	I-protein
p65	I-protein
in	O
vitro	O
and	O
may	O
impair	O
human	O
immunodeficiency	O
virus	O
replication	O
in	O
these	O
cells	O
.	O

Two	O
groups	O
of	O
U937	B-cell_line
promonocytic	I-cell_line
cells	I-cell_line
were	O
obtained	O
by	O
limiting	O
dilution	O
cloning	O
which	O
differed	O
strikingly	O
in	O
their	O
ability	O
to	O
support	O
human	O
immunodeficiency	O
virus	O
1	O
(	O
HIV-1	O
)	O
replication	O
.	O

``	B-cell_line
Plus	I-cell_line
''	I-cell_line
clones	I-cell_line
replicated	O
the	O
virus	O
efficiently	O
,	O
whereas	O
``	B-cell_line
minus	I-cell_line
''	I-cell_line
clones	I-cell_line
did	O
not	O
.	O

We	O
examined	O
these	O
clones	O
for	O
differences	O
in	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappa	I-protein
B	I-protein
activity	O
which	O
might	O
account	O
for	O
the	O
observed	O
phenomenon	O
.	O

Stimulation	O
of	O
plus	B-cell_line
clones	I-cell_line
liberated	O
the	O
classical	O
p50-p65	B-protein
complex	I-protein
from	O
cytoplasmic	O
pools	O
,	O
whereas	O
minus	B-cell_line
clones	I-cell_line
produced	O
an	O
apparently	O
novel	O
,	O
faster-migrating	B-protein
complex	I-protein
,	O
as	O
judged	O
by	O
electrophoretic	O
mobility	O
shift	O
assays	O
.	O

It	O
is	O
surprising	O
that	O
the	O
faster-migrating	B-protein
complex	I-protein
was	O
composed	O
also	O
of	O
p50	B-protein
and	O
p65	B-protein
.	O

However	O
,	O
the	O
p65	B-protein
subunit	I-protein
was	O
COOH-terminally	O
truncated	O
,	O
as	O
shown	O
by	O
immunoprecipitation	O
.	O

The	O
truncation	O
resulted	O
from	O
limited	O
proteolysis	O
of	O
p65	B-protein
during	O
cellular	O
extraction	O
which	O
released	O
particular	O
lysosomal	B-protein
serine	I-protein
proteases	I-protein
,	O
such	O
as	O
elastase	B-protein
,	O
cathepsin	B-protein
G	I-protein
,	O
and	O
proteinase	B-protein
3	I-protein
.	O

These	O
specific	O
proteases	O
are	O
coordinately	O
expressed	O
and	O
were	O
present	O
exclusively	O
in	O
the	O
minus	B-cell_line
U937	I-cell_line
clones	I-cell_line
,	O
but	O
not	O
in	O
the	O
plus	B-cell_line
clones	I-cell_line
,	O
as	O
demonstrated	O
in	O
the	O
case	O
of	O
cathepsin	B-protein
G	I-protein
.	O

In	O
addition	O
,	O
these	O
proteases	O
were	O
detected	O
in	O
certain	O
subclones	O
of	O
THP-1	B-cell_line
and	O
HL-60	B-cell_line
cells	I-cell_line
and	O
in	O
primary	O
monocytes	B-cell_type
,	O
in	O
each	O
case	O
correlating	O
with	O
the	O
truncated	O
from	O
of	O
p65	B-protein
.	O

We	O
demonstrate	O
in	O
vitro	O
cleavage	O
of	O
p65	B-protein
by	O
purified	O
elastase	B-protein
and	O
cathepsin	B-protein
G	I-protein
.	O

It	O
is	O
possible	O
that	O
particular	O
serine	B-protein
proteases	I-protein
may	O
have	O
inhibiting	O
effects	O
on	O
the	O
replication	O
of	O
HIV-1	O
in	O
myelo-monocytic	B-cell_line
cells	I-cell_line
.	O

The	O
data	O
also	O
demonstrate	O
that	O
special	O
precautions	O
must	O
be	O
taken	O
when	O
making	O
extracts	O
from	O
myelo-monocytic	B-cell_line
cells	I-cell_line
.	O

A	NULL
Family	NULL
of	NULL
Serine	NULL
Proteases	NULL
Expressed	NULL
Exclusively	NULL
in	NULL
Myelo-Monocytic	NULL
Cells	NULL
Specifically	NULL
Processes	NULL
the	NULL
Nuclear	NULL
Factor-	NULL
«	NULL
B	NULL
Subunit	NULL
p65	NULL
In	NULL
Vitro	NULL
and	NULL
May	NULL
Impair	NULL
Human	NULL
Immunodeficiency	NULL
Virus	NULL
Replication	NULL
in	NULL
These	NULL
Cells	NULL
By	NULL
Guido	NULL
Franzoso	NULL
,	NULL
Priscilla	NULL
Biswas	NULL
,	NULL
Guido	NULL
Poli	NULL
,	NULL
Louise	NULL
M.	NULL
Carlson	NULL
,	NULL
Keith	NULL
D.	NULL
Brown	NULL
,	NULL
Michiyo	NULL
Tomita-	NULL
Yamaguchi	NULL
,	NULL
Anthony	NULL
S.	NULL
Fauci	NULL
,	NULL
and	NULL
Ulrich	NULL
K.	NULL
Siebenlist	NULL
From	NULL
the	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
Summary	NULL
Two	NULL
groups	NULL
of	NULL
U937	NULL
promonocytic	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
limiting	NULL
dilution	NULL
cloning	NULL
which	NULL
differed	NULL
strikingly	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
replication	NULL
.	NULL

``	NULL
Plus	NULL
``	NULL
clones	NULL
replicated	NULL
the	NULL
virus	NULL
efficiently	NULL
,	NULL
whereas	NULL
``	NULL
minus	NULL
``	NULL
clones	NULL
did	NULL
not	NULL
.	NULL

We	NULL
examined	NULL
these	NULL
clones	NULL
for	NULL
differences	NULL
in	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-KB	NULL
activity	NULL
which	NULL
might	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
phenomenon	NULL
.	NULL

Stimulation	NULL
of	NULL
plus	NULL
clones	NULL
liberated	NULL
the	NULL
classical	NULL
p50-p65	NULL
complex	NULL
from	NULL
cytoplasmic	NULL
pools	NULL
,	NULL
whereas	NULL
minus	NULL
clones	NULL
produced	NULL
an	NULL
apparently	NULL
novel	NULL
,	NULL
faster-migrating	NULL
complex	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

It	NULL
is	NULL
surprising	NULL
that	NULL
the	NULL
faster-migrating	NULL
complex	NULL
was	NULL
composed	NULL
also	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p65	NULL
subunit	NULL
was	NULL
COOH	NULL
truncated	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
immunoprecipitation	NULL
.	NULL

The	NULL
truncation	NULL
resulted	NULL
from	NULL
limited	NULL
proteolysis	NULL
of	NULL
p65	NULL
during	NULL
cellular	NULL
extraction	NULL
which	NULL
released	NULL
particular	NULL
lysosomal	NULL
serine	NULL
proteases	NULL
,	NULL
such	NULL
as	NULL
elastase	NULL
,	NULL
cathepsin	NULL
G	NULL
,	NULL
and	NULL
proteinase	NULL
3	NULL
.	NULL

These	NULL
specific	NULL
proteases	NULL
are	NULL
coordinately	NULL
expressed	NULL
and	NULL
were	NULL
present	NULL
exclusively	NULL
in	NULL
the	NULL
minus	NULL
U937	NULL
clones	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
plus	NULL
clones	NULL
,	NULL
as	NULL
demonstrated	NULL
in	NULL
the	NULL
case	NULL
of	NULL
cathepsin	NULL
G.	NULL
In	NULL
addition	NULL
,	NULL
these	NULL
proteases	NULL
were	NULL
detected	NULL
in	NULL
certain	NULL
subclones	NULL
of	NULL
THP-1	NULL
and	NULL
HL-60	NULL
cells	NULL
and	NULL
in	NULL
primary	NULL
monocytes	NULL
,	NULL
in	NULL
each	NULL
case	NULL
correlating	NULL
with	NULL
the	NULL
truncated	NULL
form	NULL
of	NULL
p65	NULL
.	NULL

We	NULL
demonstrate	NULL
in	NULL
vitro	NULL
cleavage	NULL
of	NULL
p65	NULL
by	NULL
purified	NULL
elastase	NULL
and	NULL
cathepsin	NULL
G.	NULL
It	NULL
is	NULL
possible	NULL
that	NULL
particular	NULL
serine	NULL
proteases	NULL
may	NULL
have	NULL
inhibiting	NULL
effects	NULL
on	NULL
the	NULL
replication	NULL
of	NULL
HIV-1	NULL
in	NULL
myelo-monocytic	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
also	NULL
demonstrate	NULL
that	NULL
special	NULL
precautions	NULL
must	NULL
be	NULL
taken	NULL
when	NULL
making	NULL
extracts	NULL
from	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

he	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
'-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
number	NULL
of	NULL
genes	NULL
,	NULL
particularly	NULL
those	NULL
participating	NULL
in	NULL
immune	NULL
functions	NULL
and	NULL
acute	NULL
phase	NULL
reactions	NULL
.	NULL

Furthermore	NULL
,	NULL
several	NULL
viruses	NULL
,	NULL
including	NULL
HIV	NULL
-1	NULL
,	NULL
are	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
.	NULL

NF-KB	NULL
is	NULL
retained	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
unstimulated	NULL
cells	NULL
by	NULL
the	NULL
inhibitory	NULL
IxB-ax	NULL
protein	NULL
and	NULL
can	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
references	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
NF-KB	NULL
involves	NULL
phosphorylation	NULL
and	NULL
proteolytic	NULL
digestion	NULL
of	NULL
IxB-a	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
,	NULL
G.	NULL
Franzoso	NULL
and	NULL
P.	NULL
Biswas	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
paper	NULL
.	NULL

1	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
DFP	NULL
,	NULL
diisopropyl	NULL
fluorophosphate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
NF	NULL
,	NULL
nuclear	NULL
factor	NULL
;	NULL
PR-3	NULL
,	NULL
proteinase	NULL
3	NULL
;	NULL
TPA	NULL
,	NULL
Tetradeconoylphorbol	NULL
13-acetate	NULL
.	NULL

which	NULL
include	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
,	NULL
p52	NULL
(	NULL
NF-	NULL
«	NULL
B2	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
,	NULL
can	NULL
form	NULL
many	NULL
distinct	NULL
homo-	NULL
and	NULL
heterodimeric	NULL
complexes	NULL
;	NULL
those	NULL
containing	NULL
c-Rel	NULL
,	NULL
p65	NULL
,	NULL
or	NULL
RelB	NULL
can	NULL
be	NULL
potent	NULL
transactivators	NULL
,	NULL
whereas	NULL
homodimers	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p52	NULL
subunits	NULL
generally	NULL
are	NULL
not	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
5-8	NULL
)	NULL
.	NULL

NF-KB	NULL
is	NULL
a	NULL
strong	NULL
activator	NULL
of	NULL
HIV-1	NULL
transcription	NULL
,	NULL
particularly	NULL
in	NULL
mononuclear	NULL
phagocytic	NULL
cells	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

This	NULL
is	NULL
demonstrated	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
mutant	NULL
,	NULL
«	NULL
B-deleted	NULL
human	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
viruses	NULL
to	NULL
replicate	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
G.	NULL
Poli	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
unpublished	NULL
observations	NULL
;	NULL
12	NULL
)	NULL
.	NULL

Monocytes	NULL
and	NULL
macrophages	NULL
seem	NULL
to	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Whereas	NULL
certain	NULL
populations	NULL
of	NULL
tissue	NULL
macrophages	NULL
can	NULL
produce	NULL
high	NULL
amounts	NULL
of	NULL
virions	NULL
(	NULL
16-21	NULL
)	NULL
,	NULL
only	NULL
a	NULL
small	NULL
percentage	NULL
of	NULL
circulating	NULL
monocytes	NULL
harbor	NULL
and	NULL
release	NULL
HIV	NULL
,	NULL
in	NULL
vivo	NULL
(	NULL
22-25	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
primary	NULL
monocytes	NULL
are	NULL
variably	NULL
infectable	NULL
in	NULL
vitro	NULL
,	NULL
depending	NULL
in	NULL
part	NULL
on	NULL
whether	NULL
they	NULL
were	NULL
maintained	NULL
with	NULL
GM-CSF	NULL
or	NULL
1445	NULL
The	NULL
Journal	NULL
of	NULL
Experimental	NULL
Medicine	NULL
«	NULL
Volume	NULL
180	NULL
October	NULL
1994	NULL
1445-1456	NULL
IFN-y	NULL
(	NULL
26-31	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
notion	NULL
that	NULL
HIV	NULL
replication	NULL
is	NULL
enhanced	NULL
in	NULL
more	NULL
differentiated	NULL
host	NULL
cells	NULL
(	NULL
14	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Variability	NULL
in	NULL
HIV	NULL
replication	NULL
was	NULL
observed	NULL
also	NULL
within	NULL
different	NULL
subclones	NULL
of	NULL
monocytic	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
U937	NULL
(	NULL
33	NULL
)	NULL
and	NULL
THP-1	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
case	NULL
,	NULL
it	NULL
was	NULL
speculated	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
somehow	NULL
specifically	NULL
inhibited	NULL
in	NULL
those	NULL
THP-1	NULL
cells	NULL
that	NULL
supported	NULL
HIV	NULL
replication	NULL
poorly	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
report	NULL
here	NULL
the	NULL
analysis	NULL
of	NULL
a	NULL
number	NULL
of	NULL
U937	NULL
promonocytic	NULL
cell	NULL
subclones	NULL
that	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
HIV-1	NULL
replication	NULL
.	NULL

Whereas	NULL
some	NULL
clones	NULL
(	NULL
``	NULL
plus	NULL
``	NULL
)	NULL
allow	NULL
an	NULL
efficient	NULL
growth	NULL
of	NULL
HIV	NULL
,	NULL
``	NULL
minus	NULL
``	NULL
clones	NULL
provide	NULL
an	NULL
unfavorable	NULL
environment	NULL
for	NULL
the	NULL
virus	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
``	NULL
minus	NULL
``	NULL
clones	NULL
,	NULL
but	NULL
not	NULL
``	NULL
plus	NULL
``	NULL
clones	NULL
,	NULL
contain	NULL
a	NULL
faster-migrating	NULL
NF-kB	NULL
complex	NULL
,	NULL
detectable	NULL
also	NULL
in	NULL
certain	NULL
other	NULL
myelo-monocytic	NULL
cells	NULL
.	NULL

This	NULL
unusual	NULL
complex	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
COOH-terminal	NULL
truncation	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
,	NULL
which	NULL
is	NULL
generated	NULL
in	NULL
vitro	NULL
during	NULL
extraction	NULL
,	NULL
due	NULL
to	NULL
the	NULL
release	NULL
of	NULL
cell-	NULL
and	NULL
stage-specific	NULL
lysosomal	NULL
proteases	NULL
such	NULL
as	NULL
cathepsin	NULL
G	NULL
(	NULL
36	NULL
)	NULL
,	NULL
elastase	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
and	NULL
proteinase	NULL
3	NULL
(	NULL
PR-3	NULL
)	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
faster-migrating	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
proteases	NULL
and	NULL
correlates	NULL
also	NULL
with	NULL
the	NULL
inability	NULL
of	NULL
HIV	NULL
to	NULL
grow	NULL
well	NULL
in	NULL
minus	NULL
clone	NULL
cells	NULL
Our	NULL
data	NULL
suggest	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
such	NULL
serine	NULL
proteases	NULL
may	NULL
negatively	NULL
affect	NULL
the	NULL
life	NULL
cycle	NULL
of	NULL
HIV-1	NULL
.	NULL

We	NULL
show	NULL
that	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
macrophage	NULL
differentiating	NULL
agents	NULL
,	NULL
which	NULL
converts	NULL
them	NULL
into	NULL
productive	NULL
hosts	NULL
for	NULL
HIV	NULL
replication	NULL
(	NULL
26	NULL
,	NULL
27	NULL
,	NULL
29-31	NULL
)	NULL
,	NULL
also	NULL
dramatically	NULL
downregulates	NULL
the	NULL
proteases	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
Culture	NULL
,	NULL
Stimulations	NULL
,	NULL
and	NULL
HIV	NULL
Infections	NULL
.	NULL

-	NULL
The	NULL
HL-60	NULL
,	NULL
THP-1	NULL
,	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

SB	NULL
and	NULL
AK	NULL
represent	NULL
two	NULL
separate	NULL
U937	NULL
cell	NULL
cultures	NULL
that	NULL
were	NULL
maintained	NULL
in	NULL
the	NULL
laboratory	NULL
.	NULL

The	NULL
NTera-2	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
and	NULL
the	NULL
isolation	NULL
of	NULL
the	NULL
U937	NULL
clones	NULL
from	NULL
the	NULL
parental	NULL
cell	NULL
line	NULL
SB	NULL
(	NULL
40	NULL
)	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI-1640	NULL
supplemented	NULL
with	NULL
antibiotics	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
the	NULL
U937	NULL
clones	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
or	NULL
20	NULL
%	NULL
FCS	NULL
in	NULL
the	NULL
case	NULL
of	NULL
HL-60	NULL
cells	NULL
.	NULL

NTera-2	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
DMEM	NULL
(	NULL
10	NULL
%	NULL
FCS	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
isolated	NULL
from	NULL
healthy	NULL
donors	NULL
and	NULL
purified	NULL
by	NULL
elutriation	NULL
,	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
subsequently	NULL
either	NULL
harvested	NULL
immediately	NULL
,	NULL
or	NULL
put	NULL
in	NULL
culture	NULL
in	NULL
DMEM	NULL
(	NULL
10	NULL
%	NULL
FCS	NULL
)	NULL
.	NULL

For	NULL
the	NULL
acute	NULL
HIV	NULL
infections	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
duplicate	NULL
in	NULL
48-well	NULL
plates	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1-2.5	NULL
x	NULL
10°	NULL
ml	NULL
.	NULL

The	NULL
MN	NULL
virus	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1X	NULL
(	NULL
1,000-fold	NULL
dilution	NULL
of	NULL
a	NULL
stock	NULL
preparation	NULL
containing	NULL
~10	NULL
``	NULL
virus	NULL
particles	NULL
per	NULL
mi	NULL
)	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
twice	NULL
a	NULL
week	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
used	NULL
.	NULL

HIV	NULL
infection	NULL
was	NULL
assessed	NULL
by	NULL
detection	NULL
of	NULL
Mg**	NULL
-dependent	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
activity	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

For	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

2	NULL
and	NULL
5	NULL
,	NULL
U937	NULL
and	NULL
HL-60	NULL
cells	NULL
(	NULL
0.5	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
200	NULL
U/ml	NULL
of	NULL
TNF-a	NULL
(	NULL
Genzyme	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
time	NULL
.	NULL

In	NULL
the	NULL
other	NULL
cases	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
3-5	NULL
d	NULL
as	NULL
follows	NULL
:	NULL
(	NULL
a	NULL
)	NULL
HL-60	NULL
cells	NULL
(	NULL
0.3	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
:	NULL
107°	NULL
M	NULL
retinoic	NULL
acid	NULL
(	NULL
all-trans	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
;	NULL
1.25	NULL
%	NULL
DMSO	NULL
(	NULL
Mallinckrodt	NULL
Specialty	NULL
Chemicals	NULL
,	NULL
Chesterfield	NULL
,	NULL
MO	NULL
)	NULL
;	NULL
100	NULL
U/ml	NULL
TNF-a	NULL
;	NULL
16	NULL
ng/ml	NULL
12-O-Tetradecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
U937	NULL
clone	NULL
12	NULL
(	NULL
0.3	NULL
x	NULL
106/mil	NULL
)	NULL
:	NULL
16	NULL
ng/ml	NULL
TPA	NULL
;	NULL
(	NULL
c	NULL
)	NULL
monocytes	NULL
1446	NULL
(	NULL
0.5	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
:	NULL
10	NULL
ng/ml	NULL
IFN-y	NULL
(	NULL
Genzyme	NULL
Corp.	NULL
)	NULL
;	NULL
20	NULL
ng/m	NULL
!	NULL

GM-CSF	NULL
(	NULL
Genzyme	NULL
Corp.	NULL
)	NULL
;	NULL
200	NULL
ng/ml	NULL
LPS	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
;	NULL
and	NULL
5	NULL
ng/ml	NULL
TPA	NULL
.	NULL

Expression	NULL
Vectors	NULL
,	NULL
Cell	NULL
Extracts	NULL
,	NULL
and	NULL
Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

-	NULL
Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
buffer	NULL
C	NULL
supplemented	NULL
with	NULL
protease	NULL
inhibitors	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
protease	NULL
inhibitors	NULL
included	NULL
:	NULL
PMSF	NULL
,	NULL
0.5	NULL
mM	NULL
;	NULL
antipain-dihydrochloride	NULL
,	NULL
50	NULL
ug/ml	NULL
;	NULL
4-amidinophenyl-methanesulfonylfluo-ride	NULL
(	NULL
APMSF	NULL
)	NULL
,	NULL
40	NULL
pg/ml	NULL
;	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
;	NULL
bestatin	NULL
,	NULL
40	NULL
ug/ml	NULL
;	NULL
chymostatin	NULL
,	NULL
20	NULL
ug/ml	NULL
;	NULL
E-64	NULL
,	NULL
0.4	NULL
mg/ml	NULL
;	NULL
leupeptin	NULL
,	NULL
0.5	NULL
ug/ml	NULL
;	NULL
pepstatin	NULL
,	NULL
0.7	NULL
ug/ml	NULL
;	NULL
and	NULL
phosphoramidon	NULL
,	NULL
100	NULL
ug/ml	NULL
.	NULL

To	NULL
obtain	NULL
nuclear	NULL
extracts	NULL
,	NULL
U937	NULL
cells	NULL
were	NULL
lysed	NULL
with	NULL
0.2	NULL
%	NULL
NP-40	NULL
and	NULL
NTera-2	NULL
cells	NULL
with	NULL
a	NULL
Dounce	NULL
homogenizer	NULL
,	NULL
as	NULL
reported	NULL
elsewhere	NULL
(	NULL
3	NULL
,	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
nuclei	NULL
were	NULL
salt	NULL
extracted	NULL
in	NULL
buffer	NULL
C.	NULL
For	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
made	NULL
by	NULL
resuspending	NULL
the	NULL
cells	NULL
in	NULL
a	NULL
modified	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
NaVO4	NULL
,	NULL
30	NULL
mM	NULL
pyrophosphate	NULL
,	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
containing	NULL
the	NULL
protease	NULL
inhibitor	NULL
diisopropyl	NULL
fluorophosphate	NULL
(	NULL
DFP	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
30	NULL
mM	NULL
)	NULL
,	NULL
and	NULL
subsequent	NULL
ultracentrifugation	NULL
.	NULL

The	NULL
PMT2ZT	NULL
p50	NULL
and	NULL
PMT	NULL
2T-p65	NULL
expression	NULL
plasmids	NULL
and	NULL
the	NULL
PMT	NULL
2T	NULL
vector	NULL
,	NULL
the	NULL
transfection	NULL
protocol	NULL
,	NULL
the	NULL
EMSA	NULL
and	NULL
antibody-supershift	NULL
proce-dures	NULL
,	NULL
the	NULL
palindromic-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
PD-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Ig	NULL
x	NULL
light	NULL
chain-KB	NULL
probe	NULL
(	NULL
Ig-	NULL
«	NULL
-LC-	NULL
«	NULL
B	NULL
)	NULL
,	NULL
have	NULL
all	NULL
been	NULL
reported	NULL
(	NULL
3	NULL
,	NULL
5-8	NULL
)	NULL
.	NULL

NF-kB	NULL
heterodimers	NULL
used	NULL
in	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
7	NULL
were	NULL
obtained	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
(	NULL
4	NULL
ug	NULL
each	NULL
)	NULL
.	NULL

For	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
the	NULL
NTera-2	NULL
nuclear	NULL
extract	NULL
was	NULL
premixed	NULL
with	NULL
1	NULL
ul	NULL
of	NULL
whole	NULL
cell	NULL
extract	NULL
prepared	NULL
from	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
insertless	NULL
PMT2T	NULL
vector	NULL
(	NULL
8	NULL
ug	NULL
)	NULL
or	NULL
comparable	NULL
amounts	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
measuring	NULL
the	NULL
protein	NULL
concentration	NULL
)	NULL
of	NULL
unstimulated	NULL
clone	NULL
10	NULL
and	NULL
clone	NULL
12	NULL
cells	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
added	NULL
after	NULL
10	NULL
min	NULL
of	NULL
preincubation	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

For	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
protease	NULL
inhibitors	NULL
were	NULL
premixed	NULL
(	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
with	NULL
clone	NULL
12	NULL
cell	NULL
extract	NULL
before	NULL
being	NULL
added	NULL
to	NULL
the	NULL
NTera-2	NULL
extract	NULL
,	NULL
as	NULL
described	NULL
above	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

The	NULL
following	NULL
final	NULL
concentrations	NULL
were	NULL
used	NULL
:	NULL
bestatin	NULL
,	NULL
2	NULL
mM	NULL
;	NULL
calpain	NULL
inhibitor	NULL
I	NULL
,	NULL
3	NULL
mM	NULL
;	NULL
calpain	NULL
inhibitor	NULL
II	NULL
(	NULL
all	NULL
from	NULL
Boehringer	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
;	NULL
N-tosyl-phenylalany	NULL
!	NULL

-chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
;	NULL
APMSF	NULL
,	NULL
2	NULL
ug/ul	NULL
;	NULL
aprotinin	NULL
(	NULL
both	NULL
from	NULL
Beohringer	NULL
)	NULL
,	NULL
0.6	NULL
ug/ul	NULL
;	NULL
N-tosyl-lysyl-chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
,	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
;	NULL
antipain-dihydrochloride	NULL
,	NULL
2	NULL
mM	NULL
;	NULL
pepstatin	NULL
,	NULL
0.8	NULL
ug/ul	NULL
;	NULL
leupeptin	NULL
,	NULL
2	NULL
mM	NULL
;	NULL
phosphoramidon	NULL
,	NULL
5	NULL
ug/pul	NULL
;	NULL
4-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
-benzenesulfonyl	NULL
fluoride	NULL
(	NULL
AEBSF	NULL
;	NULL
all	NULL
from	NULL
Boehringer	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
;	NULL
N-CBZ-1-phenylalanine-chloromethyl	NULL
ketone	NULL
(	NULL
ZPCK	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
;	NULL
io-doacetamide	NULL
(	NULL
IAA	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
;	NULL
N-ethylmaleimide	NULL
(	NULL
NTM	NULL
;	NULL
all	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
1	NULL
mM	NULL
;	NULL
BSA	NULL
fraction	NULL
V	NULL
(	NULL
Pentex	NULL
,	NULL
Kankakee	NULL
,	NULL
IL	NULL
)	NULL
,	NULL
5	NULL
ug/pul	NULL
;	NULL
rabbit	NULL
preimmune	NULL
serum	NULL
,	NULL
10	NULL
%	NULL
;	NULL
DFP	NULL
,	NULL
3	NULL
mM	NULL
;	NULL
3,4-dichloroisocoumarin	NULL
(	NULL
DIC	NULL
;	NULL
both	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
;	NULL
e	NULL
«	NULL
1-antitrypsin	NULL
(	NULL
Calbiochem-Novabiochem	NULL
Corp.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
3	NULL
ug/pul	NULL
;	NULL
and	NULL
chymostatin	NULL
(	NULL
Boehringer	NULL
)	NULL
,	NULL
6	NULL
mM	NULL
.	NULL

Purified	NULL
elastase	NULL
and	NULL
cathepsin	NULL
G	NULL
enzymes	NULL
were	NULL
purchased	NULL
as	NULL
powder	NULL
(	NULL
all	NULL
from	NULL
Calbiochem	NULL
Novabiochem	NULL
Corp.	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
PBS	NULL
(	NULL
with	NULL
15	NULL
%	NULL
glycerol	NULL
)	NULL
at	NULL
a	NULL
1	NULL
mg/ml	NULL
stock	NULL
concentration	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Westen	NULL
Blot	NULL
.	NULL

-	NULL
Immunoprecipitations	NULL
were	NULL
performed	NULL
with	NULL
rabbit	NULL
anti-p65	NULL
antibodies	NULL
on	NULL
whole	NULL
cell	NULL
extracts	NULL
(	NULL
10	NULL
'	NULL
cells/reaction	NULL
)	NULL
,	NULL
as	NULL
described	NULL
(	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
antigen-antibody	NULL
complexes	NULL
were	NULL
precipitated	NULL
with	NULL
protein	NULL
A-Sepharose	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
anal-ysis	NULL
:	NULL
the	NULL
primary	NULL
antibody	NULL
was	NULL
an	NULL
anti-p65	NULL
mouse	NULL
polyclonal	NULL
antibody	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
276	NULL
to	NULL
502	NULL
,	NULL
and	NULL
the	NULL
secondary	NULL
In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL
antibody	NULL
was	NULL
a	NULL
sheep	NULL
anti-mouse	NULL
``	NULL
I-labeled	NULL
antibody	NULL
(	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

The	NULL
same	NULL
standard	NULL
conditions	NULL
were	NULL
used	NULL
for	NULL
the	NULL
direct	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
except	NULL
that	NULL
less	NULL
extract	NULL
was	NULL
used	NULL
(	NULL
corresponding	NULL
to	NULL
3	NULL
x	NULL
10°	NULL
cells/lane	NULL
)	NULL
and	NULL
the	NULL
antigen-antibody	NULL
reaction	NULL
was	NULL
developed	NULL
with	NULL
I-labeled	NULL
protein	NULL
A	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

'The	NULL
antibodies	NULL
used	NULL
were	NULL
:	NULL
(	NULL
a	NULL
)	NULL
a	NULL
rabbit	NULL
p65	NULL
NH	NULL
;	NULL
-terminal	NULL
peptide	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
;	NULL
[	NULL
5	NULL
]	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
a	NULL
rabbit	NULL
antibody	NULL
directed	NULL
to	NULL
a	NULL
COOH-terminal	NULL
peptide	NULL
of	NULL
p65	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
5	NULL
B	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
a	NULL
mouse	NULL
and	NULL
a	NULL
rabbit	NULL
p65	NULL
polyclonal	NULL
antibody	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
276	NULL
to	NULL
502	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
6	NULL
A	NULL
)	NULL
;	NULL
(	NULL
d	NULL
)	NULL
a	NULL
p50	NULL
peptide	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
;	NULL
[	NULL
5	NULL
]	NULL
)	NULL
;	NULL
(	NULL
e	NULL
)	NULL
an	NULL
antibody	NULL
recognizing	NULL
an	NULL
NH	NULL
;	NULL
-terminal	NULL
peptide	NULL
of	NULL
p52	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
;	NULL
[	NULL
8	NULL
]	NULL
)	NULL
;	NULL
(	NULL
f	NULL
)	NULL
a	NULL
c-Rel	NULL
COOH-terminal	NULL
antipeptide	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
;	NULL
[	NULL
43	NULL
}	NULL
)	NULL
;	NULL
and	NULL
(	NULL
g	NULL
)	NULL
a	NULL
commercially	NULL
available	NULL
anticathepsin	NULL
G	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
;	NULL
obtained	NULL
from	NULL
Calbiochem-Novabiochem	NULL
Corp	NULL
)	NULL
.	NULL

Results	NULL
Subclones	NULL
of	NULL
U937	NULL
Cells	NULL
Differ	NULL
in	NULL
Their	NULL
Ability	NULL
to	NULL
Support	NULL
HIV	NULL
-1	NULL
Replication	NULL
.	NULL

-	NULL
45	NULL
cell	NULL
clones	NULL
were	NULL
obtained	NULL
by	NULL
limiting	NULL
dilution	NULL
from	NULL
the	NULL
parental	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
SB	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Two	NULL
distinct	NULL
groups	NULL
of	NULL
clones	NULL
could	NULL
be	NULL
discerned	NULL
based	NULL
on	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
HIV-1	NULL
replication	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

One	NULL
group	NULL
of	NULL
clones	NULL
(	NULL
plus	NULL
)	NULL
exhibited	NULL
kinetics	NULL
of	NULL
infection	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
the	NULL
parental	NULL
U937	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
another	NULL
group	NULL
(	NULL
minus	NULL
clones	NULL
)	NULL
consistently	NULL
exhibited	NULL
markedly	NULL
delayed	NULL
kinetics	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
.	NULL

The	NULL
impaired	NULL
ability	NULL
of	NULL
HIV	NULL
to	NULL
efficiently	NULL
replicate	NULL
in	NULL
minus	NULL
clones	NULL
was	NULL
not	NULL
explained	NULL
by	NULL
the	NULL
lack	NULL
or	NULL
reduced	NULL
expression	NULL
of	NULL
membrane	NULL
CD4	NULL
molecules	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
another	NULL
study	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Extracts	NULL
From	NULL
U937	NULL
Minus	NULL
Subclones	NULL
Contain	NULL
a	NULL
Modified	NULL
NF-kB	NULL
Complex	NULL
.	NULL

-	NULL
We	NULL
sought	NULL
differences	NULL
in	NULL
U937	NULL
subclones	NULL
that	NULL
might	NULL
account	NULL
for	NULL
the	NULL
HIV	NULL
growth	NULL
data	NULL
.	NULL

Individual	NULL
subclones	NULL
and	NULL
the	NULL
U937	NULL
clone	NULL
AK	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
left	NULL
untreated	NULL
.	NULL

Extracts	NULL
from	NULL
all	NULL
cells	NULL
gave	NULL
rise	NULL
to	NULL
a	NULL
single	NULL
,	NULL
constitutive	NULL
band	NULL
in	NULL
EMSAs	NULL
which	NULL
was	NULL
due	NULL
to	NULL
homodimers	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
[	NULL
>	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
for	NULL
another	NULL
U937	NULL
clone	NULL
(	NULL
5	NULL
;	NULL
see	NULL
also	NULL
below	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
TNF-a	NULL
induced	NULL
an	NULL
additional	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
,	NULL
but	NULL
individual	NULL
clones	NULL
differed	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
induced	NULL
band	NULL
shift	NULL
:	NULL
plus	NULL
clones	NULL
(	NULL
Nos	NULL
.	NULL

30	NULL
,	NULL
10	NULL
,	NULL
31	NULL
,	NULL
and	NULL
the	NULL
parental	NULL
line	NULL
SB	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
yielded	NULL
the	NULL
traditional	NULL
p50-p65	NULL
NF-	NULL
«	NULL
B	NULL
species	NULL
(	NULL
W	NULL
,	NULL
left	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
which	NULL
migrated	NULL
more	NULL
slowly	NULL
than	NULL
p50	NULL
homodimers	NULL
,	NULL
whereas	NULL
minus	NULL
clones	NULL
(	NULL
Nos	NULL
.	NULL

34	NULL
,	NULL
12	NULL
,	NULL
and	NULL
the	NULL
AK	NULL
line	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
4	NULL
)	NULL
yielded	NULL
an	NULL
induced	NULL
and	NULL
apparently	NULL
novel	NULL
,	NULL
more	NULL
diffuse	NULL
complex	NULL
which	NULL
largely	NULL
comigrated	NULL
with	NULL
the	NULL
p50	NULL
homodimers	NULL
(	NULL
«	NULL
,	NULL
right	NULL
,	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
an	NULL
HL-60	NULL
subline	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
also	NULL
exhibited	NULL
this	NULL
faster-migrating	NULL
complex	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
below	NULL
also	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
mobilities	NULL
of	NULL
the	NULL
TNF-ox-induced	NULL
complexes	NULL
generated	NULL
from	NULL
the	NULL
two	NULL
types	NULL
of	NULL
clones	NULL
,	NULL
both	NULL
complexes	NULL
contained	NULL
p50	NULL
and	NULL
p65	NULL
polypeptides	NULL
and	NULL
not	NULL
some	NULL
other	NULL
Rel-related	NULL
proteins	NULL
,	NULL
as	NULL
demonstrated	NULL
with	NULL
supershifting	NULL
antibodies	NULL
specific	NULL
to	NULL
these	NULL
NF-KB	NULL
subunits	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
43	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
,	NULL
faster-migrating	NULL
complex	NULL
from	NULL
1447	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

40,000	NULL
r	NULL
©	NULL
U937	NULL
SB	NULL
Parental	NULL
M	NULL
Clone	NULL
10	NULL
30,000	NULL
L	NULL
©	NULL
Clone	NULL
30	NULL
is	NULL
A	NULL
&	NULL
Cione	NULL
31	NULL
E	NULL
ts	NULL
»	NULL
20,000	NULL
}	NULL
2	NULL
3	NULL
E	NULL
10,000	NULL
0	NULL
1	NULL
4	NULL
1	NULL
J	NULL
40,000	NULL
r	NULL
©	NULL
U937	NULL
SB	NULL
Parental	NULL
CJ	NULL
Clone	NULL
17	NULL
3	NULL
30,000	NULL
|-	NULL
O	NULL
Clone	NULL
12	NULL
E	NULL
A	NULL
Clone	NULL
34	NULL
g	NULL
®	NULL
-	NULL
U937	NULL
AK	NULL
€	NULL
2o.ooo	NULL
}	NULL
tC	NULL
<	NULL
'	NULL
_	NULL
CC	NULL
10,000	NULL
|	NULL
-	NULL
e	NULL
--	NULL
R	NULL
@	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Days	NULL
Figure	NULL
1	NULL
.	NULL

-	NULL
U937-derived	NULL
cell	NULL
clones	NULL
differentially	NULL
support	NULL
HIV	NULL
replication	NULL
.	NULL

Infections	NULL
of	NULL
plus	NULL
(	NULL
4	NULL
)	NULL
and	NULL
minus	NULL
(	NULL
B	NULL
)	NULL
U937	NULL
cell	NULL
clones	NULL
in	NULL
vitro	NULL
,	NULL
with	NULL
the	NULL
MN	NULL
strain	NULL
of	NULL
HIV-1	NULL
(	NULL
Advanced	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Columbia	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Experiments	NULL
were	NULL
repeated	NULL
four	NULL
times	NULL
.	NULL

The	NULL
result	NULL
of	NULL
a	NULL
representative	NULL
infection	NULL
is	NULL
shown	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
also	NULL
with	NULL
the	NULL
IIIB	NULL
strain	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
parental	NULL
U937	NULL
cell	NULL
line	NULL
SB	NULL
and	NULL
the	NULL
U937-derived	NULL
clones	NULL
were	NULL
negative	NULL
for	NULL
mycoplasma	NULL
contamination	NULL
as	NULL
determined	NULL
by	NULL
two	NULL
sequential	NULL
screenings	NULL
.	NULL

HL-60	NULL
cells	NULL
was	NULL
also	NULL
predominantly	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
modified	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
was	NULL
seen	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
myelo-monocytic	NULL
lineage	NULL
,	NULL
but	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
many	NULL
other	NULL
cells	NULL
including	NULL
T	NULL
,	NULL
B	NULL
,	NULL
and	NULL
nonhema-topoietic	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Modified	NULL
NF-	NULL
«	NULL
B	NULL
Complex	NULL
Contains	NULL
a	NULL
Truncated	NULL
p65	NULL
Subunit	NULL
.	NULL

-	NULL
To	NULL
characterize	NULL
the	NULL
novel	NULL
NF-KB	NULL
complex	NULL
,	NULL
extracts	NULL
from	NULL
various	NULL
U937	NULL
clones	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
three	NULL
different	NULL
antibodies	NULL
directed	NULL
against	NULL
p65	NULL
and	NULL
subsequently	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
a	NULL
polyclonal	NULL
p65	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

All	NULL
three	NULL
antibodies	NULL
precipitated	NULL
a	NULL
protein	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
~69	NULL
kD	NULL
when	NULL
extracts	NULL
obtained	NULL
from	NULL
the	NULL
parental	NULL
line	NULL
SB	NULL
and	NULL
clone	NULL
30	NULL
were	NULL
used	NULL
.	NULL

This	NULL
protein	NULL
comigrated	NULL
with	NULL
p65	NULL
from	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
its	NULL
immunoprecipitation	NULL
was	NULL
blocked	NULL
by	NULL
specific	NULL
A	NULL
u937	NULL
[	NULL
clone	NULL
:	NULL
clone	NULL
30	NULL
_	NULL
clone	NULL
10	NULL
SB	NULL
clone	NULL
31	NULL
_	NULL
clone	NULL
34	NULL
AK	NULL
1	NULL
clone	NULL
12	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Extracts	NULL
from	NULL
different	NULL
U937	NULL
subclones	NULL
con	NULL
TNF-alpha	NULL
:	NULL
|	NULL
=	NULL
$	NULL
00	NULL
=	NULL
o	NULL
$	NULL
00	NULL
=	NULL
$	NULL
000	NULL
-	NULL
$	NULL
o	NULL
o-	NULL
+	NULL
tain	NULL
distinct	NULL
TNF-	NULL
«	NULL
x	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
,	NULL
yet	NULL
both	NULL
are	NULL
composed	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSAs	NULL
of	NULL
whole	NULL
cell	NULL
Clone	NULL
10	NULL
unstimulated	NULL
TNF-alpha	NULL
|	NULL
H	NULL
1	NULL
A	NULL
A	NULL
o	NULL
1	NULL
L	NULL
e	NULL
8	NULL
A	NULL
&	NULL
@	NULL
<	NULL
-_	NULL
?	NULL

JP	NULL
C	NULL
&	NULL
-	NULL
4C	NULL
4°	NULL
$	NULL
0	NULL
Ab	NULL
supershift	NULL
:	NULL
V_Y¥	NULL
8	NULL
9	NULL
10	NULL
p65	NULL
peptide	NULL
competition	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
cell	NULL
extracts	NULL
from	NULL
clone	NULL
12	NULL
and	NULL
34	NULL
were	NULL
tested	NULL
,	NULL
the	NULL
polyclonal	NULL
antibody	NULL
and	NULL
the	NULL
peptide	NULL
antibody	NULL
predominantly	NULL
recognized	NULL
a	NULL
shorter	NULL
form	NULL
of	NULL
p65	NULL
(	NULL
about	NULL
50	NULL
kD	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
COOH-terminal	NULL
peptide	NULL
antibody	NULL
failed	NULL
to	NULL
detect	NULL
any	NULL
band	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
observed	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
contained	NULL
a	NULL
form	NULL
of	NULL
p65	NULL
that	NULL
was	NULL
truncated	NULL
at	NULL
the	NULL
COOH	NULL
-terminus	NULL
.	NULL

Given	NULL
the	NULL
size	NULL
of	NULL
the	NULL
resulting	NULL
pro-tein	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
truncation	NULL
occurred	NULL
just	NULL
after	NULL
the	NULL
Rel-homology	NULL
domain	NULL
(	NULL
RHD	NULL
)	NULL
,	NULL
preserving	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
dimerize	NULL
and	NULL
bind	NULL
DNA	NULL
(	NULL
as	NULL
shown	NULL
above	NULL
)	NULL
,	NULL
but	NULL
1448	NULL
extracts	NULL
from	NULL
unstimulated	NULL
(	NULL
odd-numbered	NULL
lanes	NULL
)	NULL
or	NULL
TNF-	NULL
(	NULL
even-numbered	NULL
lanes	NULL
)	NULL
U937	NULL
clones	NULL
.	NULL

(	NULL
t	NULL
>	NULL
)	NULL
Specific	NULL
constitutive	NULL
and	NULL
(	NULL
P	NULL
»	NULL
,	NULL
«	NULL
@	NULL
)	NULL
TNF-o-induced	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Supershift	NULL
analysis	NULL
on	NULL
nuclear	NULL
extracts	NULL
of	NULL
the	NULL
representative	NULL
clones	NULL
10	NULL
(	NULL
B	NULL
)	NULL
and	NULL
12	NULL
(	NULL
C	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
previously	NULL
described	NULL
antibodies	NULL
,	NULL
directed	NULL
against	NULL
the	NULL
NH	NULL
;	NULL
-	NULL
‘	NULL
terminal	NULL
peptides	NULL
of	NULL
p50	NULL
(	NULL
B	NULL
and	NULL
C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
)	NULL
(	NULL
5	NULL
)	NULL
,	NULL
p50B	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
)	NULL
(	NULL
8	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
)	NULL
(	NULL
5	NULL
)	NULL
or	NULL
a	NULL
COOH-terminal	NULL
peptide	NULL
of	NULL
the	NULL
human	NULL
c-Rel	NULL
protein	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
TNF-	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
.	NULL

(	NULL
¥	NULL
,	NULL
«	NULL
@	NULL
)	NULL
p50-p65	NULL
heterodimers	NULL
and	NULL
(	NULL
A	NULL
)	NULL
p50	NULL
homodimers	NULL
.	NULL

The	NULL
two	NULL
dots	NULL
on	NULL
the	NULL
right	NULL
side	NULL
show	NULL
the	NULL
supershifts	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
extract	NULL
used	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
the	NULL
Ig-	NULL
«	NULL
LC-KB	NULL
probe	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Clone	NULL
12	NULL
unstimulated	NULL
TNF-alpha	NULL
I	NULL
1	NULL
&	NULL
99	NULL
G	NULL
1	NULL
90	NULL
&	NULL
0	NULL
&	NULL
re	NULL
Ab	NULL
supershift	NULL
__	NULL
-F	NULL
P	NULL
``	NULL
Po	NULL
g	NULL
e	NULL
a	NULL
?	NULL
``	NULL

P	NULL
eliminating	NULL
the	NULL
transactivating	NULL
domain	NULL
(	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

This	NULL
conclusion	NULL
was	NULL
supported	NULL
by	NULL
gel	NULL
shift	NULL
analysis	NULL
since	NULL
anti-p65	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
COOH-terminal	NULL
peptide	NULL
did	NULL
not	NULL
supershift	NULL
the	NULL
novel	NULL
complex	NULL
induced	NULL
in	NULL
clone	NULL
12	NULL
cells	NULL
or	NULL
in	NULL
our	NULL
HL-60	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Truncated	NULL
p65	NULL
Subunit	NULL
Is	NULL
Generated	NULL
Via	NULL
Proteolytic	NULL
Pro-cessing	NULL
.	NULL

-	NULL
To	NULL
directly	NULL
test	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
proteases	NULL
capable	NULL
of	NULL
truncating	NULL
p65	NULL
,	NULL
we	NULL
mixed	NULL
unstimulated	NULL
U937	NULL
clones	NULL
10	NULL
and	NULL
12	NULL
whole	NULL
cell	NULL
extracts	NULL
(	NULL
which	NULL
did	NULL
not	NULL
contain	NULL
appreciable	NULL
amounts	NULL
of	NULL
DNA	NULL
binding	NULL
heterodimers	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
with	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL
Parental	NULL
(	NULL
SB	NULL
)	NULL
Clone	NULL
30	NULL
Clone	NULL
12	NULL
Clone	NULL
34	NULL
r	NULL
+	NULL
p65	NULL
antibodies	NULL
to	NULL
:	NULL
N-ter	NULL
.	NULL

peptide	NULL
+	NULL
a.a.	NULL
276-502	NULL
C-ter	NULL
.	NULL

peptide	NULL
Blocking	NULL
peptide	NULL
Figure	NULL
3	NULL
.	NULL

Demonstration	NULL
of	NULL
a	NULL
truncated	NULL
form	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
in	NULL
certain	NULL
U937	NULL
clone	NULL
extracts	NULL
.	NULL

Immunoprecipitation	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
p65-specific	NULL
antibodies	NULL
on	NULL
whole	NULL
cell	NULL
extracts	NULL
of	NULL
representative	NULL
U937	NULL
clones	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
with	NULL
a	NULL
mouse	NULL
polyclonal	NULL
p65	NULL
anti-body	NULL
.	NULL

(	NULL
P	NULL
»	NULL
,	NULL
«	NULL
)	NULL
Specific	NULL
bands	NULL
;	NULL
(	NULL
[	NULL
>	NULL
)	NULL
|	NULL
points	NULL
to	NULL
the	NULL
background	NULL
due	NULL
to	NULL
the	NULL
|	NULL
presence	NULL
of	NULL
the	NULL
heavy	NULL
chain	NULL
of	NULL
the	NULL
antibodies	NULL
used	NULL
for	NULL
the	NULL
immunoprecipitation	NULL
.	NULL

-	NULL
Immunoprecipitations	NULL
performed	NULL
with	NULL
peptide	NULL
antibodies	NULL
were	NULL
blocked	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
p65	NULL
peptide	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
antibody	NULL
(	NULL
N-ter	NULL
.	NULL

peptide	NULL
:	NULL
lanes	NULL
2	NULL
,	NULL
7	NULL
,	NULL
12	NULL
,	NULL
and	NULL
17	NULL
;	NULL
C-ter	NULL
.	NULL

peptide	NULL
:	NULL
lanes	NULL
5	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
and	NULL
20	NULL
)	NULL
.	NULL

Extracts	NULL
from	NULL
the	NULL
various	NULL
U937	NULL
clones	NULL
and	NULL
the	NULL
antibodies	NULL
were	NULL
p50	NULL
and	NULL
p65	NULL
expression	NULL
vectors	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
transfected	NULL
NTera-2	NULL
cells	NULL
alone	NULL
gave	NULL
rise	NULL
to	NULL
both	NULL
p50	NULL
homodimers	NULL
and	NULL
p50-p65	NULL
heterodimers	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
of	NULL
clone	NULL
12	NULL
(	NULL
minus	NULL
)	NULL
,	NULL
but	NULL
not	NULL
of	NULL
clone	NULL
10	NULL
(	NULL
plus	NULL
)	NULL
,	NULL
generated	NULL
a	NULL
faster-moving	NULL
complex	NULL
comigrating	NULL
with	NULL
the	NULL
novel	NULL
complex	NULL
seen	NULL
with	NULL
stimulated	NULL
minus	NULL
clones	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
active	NULL
proteases	NULL
were	NULL
present	NULL
in	NULL
lysates	NULL
of	NULL
clone	NULL
12	NULL
,	NULL
which	NULL
converted	NULL
a	NULL
normal	NULL
p50-p65	NULL
complex	NULL
into	NULL
a	NULL
faster-migrating	NULL
one	NULL
,	NULL
whereas	NULL
no	NULL
such	NULL
proteases	NULL
were	NULL
present	NULL
in	NULL
extracts	NULL
of	NULL
clone	NULL
10	NULL
,	NULL
a	NULL
clone	NULL
that	NULL
gave	NULL
rise	NULL
to	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
when	NULL
stimulated	NULL
.	NULL

In	NULL
an	NULL
attempt	NULL
to	NULL
identify	NULL
this	NULL
protease	NULL
(	NULL
s	NULL
)	NULL
,	NULL
we	NULL
assayed	NULL
a	NULL
number	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
including	NULL
many	NULL
not	NULL
normally	NULL
present	NULL
in	NULL
the	NULL
extraction	NULL
cocktail	NULL
;	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
prevent	NULL
clone	NULL
12	NULL
lysates	NULL
from	NULL
converting	NULL
the	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
into	NULL
the	NULL
faster-migrating	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
protease	NULL
inhibitors	NULL
bestatin	NULL
,	NULL
APMSF	NULL
,	NULL
aprotinin	NULL
,	NULL
antipain-dihydrochloride	NULL
,	NULL
pepstatin	NULL
,	NULL
leupeptin	NULL
,	NULL
phosphoramidon	NULL
,	NULL
AEBSF	NULL
,	NULL
and	NULL
chymostatin	NULL
are	NULL
normally	NULL
included	NULL
in	NULL
the	NULL
cocktail	NULL
used	NULL
during	NULL
extraction	NULL
.	NULL

Among	NULL
these	NULL
,	NULL
only	NULL
chymostatin	NULL
has	NULL
some	NULL
activity	NULL
towards	NULL
these	NULL
proteases	NULL
,	NULL
but	NULL
its	NULL
concentration	NULL
in	NULL
normal	NULL
extraction	NULL
procedures	NULL
is	NULL
far	NULL
lower	NULL
than	NULL
that	NULL
required	NULL
for	NULL
efficient	NULL
inhibition	NULL
.	NULL

DIC	NULL
,	NULL
DFP	NULL
,	NULL
and	NULL
ex1-antitrypsin	NULL
efficiently	NULL
blocked	NULL
the	NULL
truncation	NULL
of	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
lanes	NULL
19	NULL
,	NULL
20	NULL
,	NULL
and	NULL
21	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Rabbit	NULL
preimmune	NULL
serum	NULL
,	NULL
but	NULL
not	NULL
BSA	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
lanes	NULL
18	NULL
and	NULL
17	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
could	NULL
also	NULL
weakly	NULL
inhibit	NULL
p65	NULL
proteolysis	NULL
,	NULL
probably	NULL
because	NULL
of	NULL
naturally	NULL
present	NULL
protease	NULL
inhibitors	NULL
in	NULL
serum	NULL
such	NULL
as	NULL
a1-antitrypsin	NULL
and	NULL
2-macroglobulin	NULL
(	NULL
46	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
inhibitors	NULL
target	NULL
serine	NULL
proteases	NULL
,	NULL
although	NULL
with	NULL
different	NULL
fine	NULL
specificities	NULL
.	NULL

The	NULL
Truncation	NULL
of	NULL
p65	NULL
Occurs	NULL
In	NULL
Vitro	NULL
During	NULL
the	NULL
Extraction	NULL
Procedure	NULL
.	NULL

Cell	NULL
extracts	NULL
of	NULL
clone	NULL
12	NULL
and	NULL
HL60	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protease	NULL
inhibitor	NULL
DFP	NULL
allowed	NULL
the	NULL
detection	NULL
of	NULL
wild-type	NULL
p50-p65	NULL
heterodimers	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
of	NULL
1449	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
9	NULL
20	NULL
used	NULL
as	NULL
indicated	NULL
.	NULL

full-length	NULL
p65	NULL
.	NULL

This	NULL
was	NULL
demonstrated	NULL
directly	NULL
by	NULL
the	NULL
use	NULL
of	NULL
supershifting	NULL
antibodies	NULL
recognizing	NULL
the	NULL
COOH-terminal	NULL
peptide	NULL
of	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
and	NULL
by	NULL
immunoprecipitation	NULL
experiments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
truncation	NULL
of	NULL
p65	NULL
occurs	NULL
during	NULL
extraction	NULL
rather	NULL
than	NULL
in	NULL
living	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
strong	NULL
induction	NULL
of	NULL
IkB-a	NULL
synthesis	NULL
,	NULL
observed	NULL
after	NULL
TNF-	NULL
«	NULL
stimulation	NULL
of	NULL
clone	NULL
10	NULL
and	NULL
clone	NULL
12	NULL
cells	NULL
,	NULL
provides	NULL
further	NULL
indirect	NULL
evidence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
wild-type	NULL
p65	NULL
in	NULL
all	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Truncated	NULL
p65	NULL
lacks	NULL
transactivation	NULL
domains	NULL
and	NULL
thus	NULL
would	NULL
not	NULL
be	NULL
expected	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
IkB-a	NULL
,	NULL
a	NULL
gene	NULL
whose	NULL
promoter	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
depend	NULL
on	NULL
functional	NULL
NF-KB	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
47	NULL
,	NULL
48	NULL
)	NULL
.	NULL

A	NULL
Family	NULL
of	NULL
Serine	NULL
Proteases	NULL
Are	NULL
Likely	NULL
Responsible	NULL
for	NULL
the	NULL
In	NULL
Vitro	NULL
Degradation	NULL
of	NULL
p65	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
presumed	NULL
serine	NULL
proteases	NULL
responsible	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
truncation	NULL
of	NULL
p65	NULL
,	NULL
we	NULL
tested	NULL
other	NULL
cells	NULL
,	NULL
using	NULL
the	NULL
proteolysis	NULL
of	NULL
p65	NULL
as	NULL
an	NULL
indicator	NULL
of	NULL
protease	NULL
activity	NULL
.	NULL

Truncated	NULL
form	NULL
(	NULL
s	NULL
)	NULL
of	NULL
p65	NULL
were	NULL
not	NULL
restricted	NULL
to	NULL
certain	NULL
U937	NULL
clones	NULL
,	NULL
but	NULL
could	NULL
also	NULL
be	NULL
observed	NULL
in	NULL
extracts	NULL
of	NULL
several	NULL
other	NULL
cells	NULL
,	NULL
including	NULL
a	NULL
HL-60	NULL
cell	NULL
line	NULL
(	NULL
as	NULL
discussed	NULL
above	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
THP-1	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
PBLs	NULL
contained	NULL
primarily	NULL
a	NULL
full-length	NULL
p65	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
surprising	NULL
that	NULL
full-length	NULL
p65	NULL
could	NULL
be	NULL
induced	NULL
in	NULL
all	NULL
U937	NULL
minus	NULL
clones	NULL
,	NULL
HL-60	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
in	NULL
primary	NULL
monocytes	NULL
when	NULL
these	NULL
cells	NULL
were	NULL
differentiated	NULL
for	NULL
several	NULL
days	NULL
with	NULL
agents	NULL
such	NULL
as	NULL
phorbol	NULL
ester	NULL
,	NULL
TNF-a	NULL
,	NULL
IFN-y	NULL
,	NULL
GM-CSF	NULL
,	NULL
or	NULL
LPS	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
extracts	NULL
obtained	NULL
from	NULL
clone	NULL
12	NULL
cells	NULL
differentiated	NULL
with	NULL
TPA	NULL
for	NULL
several	NULL
days	NULL
were	NULL
no	NULL
longer	NULL
able	NULL
to	NULL
process	NULL
p65	NULL
or	NULL
change	NULL
the	NULL
mobility	NULL
of	NULL
the	NULL
p50-p65	NULL
heterodimers	NULL
derived	NULL
from	NULL
NTera-2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
TPA	NULL
downregulated	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
implicated	NULL
proteases	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
the	NULL
HL-60	NULL
cells	NULL
with	NULL
retinoic	NULL
acid	NULL
or	NULL
DMSO	NULL
,	NULL
which	NULL
promote	NULL
differentiation	NULL
into	NULL
granulocytes	NULL
as	NULL
opposed	NULL
to	NULL
macrophages	NULL
(	NULL
49	NULL
)	NULL
,	NULL
did	NULL
not	NULL
downregulate	NULL
the	NULL
proteases	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
a	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
including	NULL
elastase	NULL
0	NULL
.	NULL

.	NULL

&	NULL
0°	NULL
?	NULL
)	NULL

\0	NULL
<	NULL
\	NULL
preincubation	NULL
with	NULL
:	NULL
-	NULL
G	NULL
G	NULL
>	NULL
|	NULL
#	NULL
#	NULL
>	NULL
W	NULL
|	NULL
<	NULL
1	NULL
2	NULL
3	NULL
B	NULL
<	NULL
\	NULL
Milks	NULL
(	NULL
035°	NULL
<	NULL
5	NULL
so	NULL
.	NULL

«	NULL
C6	NULL
\o	NULL
g	NULL
Q0	NULL
(	NULL
‘	NULL
é	NULL
’	NULL
oﬁ	NULL
$	NULL
323	NULL
{	NULL
1p	NULL
C5	NULL
¢	NULL
«	NULL
&	NULL
C	NULL
SCAP	NULL
inhibitor	NULL
Figure	NULL
4	NULL
.	NULL

Extracts	NULL
from	NULL
certain	NULL
U937	NULL
clones	NULL
contain	NULL
a	NULL
protease	NULL
activity	NULL
which	NULL
<	NULL
éf	NULL
qﬁ	NULL
‘	NULL
xﬁ	NULL
‘	NULL
specifically	NULL
affects	NULL
the	NULL
electrophoretic	NULL
mo-4°	NULL
a	NULL
S	NULL
&	NULL
``	NULL
bility	NULL
of	NULL
exogenously	NULL
added	NULL
p50-p65	NULL
het-Y	NULL
oP	NULL
oC	NULL
&	NULL
&	NULL
8	NULL
erodimers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
performed	NULL
with	NULL
a	NULL
nu-€	NULL
O	NULL
O	NULL
G	NULL
clear	NULL
extract	NULL
obtained	NULL
from	NULL
transfected	NULL
tw	NULL
bn	NULL
bt	NULL
th	NULL
ws	NULL
tb	NULL
tb	NULL
tb	NULL
tt	NULL
tb	NULL
tb	NULL
ap	NULL
to	NULL
t	NULL
w	NULL
bb	NULL
as	NULL
<	NULL
NTera-2	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
6	NULL
;	NULL
for	NULL
details	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

NTera-2	NULL
(	NULL
[	NULL
>	NULL
)	NULL
p50-p50	NULL
and	NULL
(	NULL
W	NULL
»	NULL
)	NULL
p50-p65	NULL
complexes	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
;	NULL
(	NULL
«	NULL
@	NULL
)	NULL
modified	NULL
heterodimers	NULL
are	NULL
on	NULL
the	NULL
right	NULL
.	NULL

(	NULL
B	NULL
)	NULL
In	NULL
vitro	NULL
cleavage	NULL
of	NULL
the	NULL
p50-p65	NULL
complex	NULL
is	NULL
selectively	NULL
blocked	NULL
by	NULL
serine	NULL
protease	NULL
inhibitors	NULL
.	NULL

NTera-2	NULL
and	NULL
clone	NULL
12	NULL
extracts	NULL
were	NULL
premixed	NULL
as	NULL
described	NULL
in	NULL
A	NULL
,	NULL
except	NULL
that	NULL
clone	NULL
12	NULL
extract	NULL
was	NULL
pretreated	NULL
with	NULL
the	NULL
indicated	NULL
protease	NULL
inhibitor	NULL
(	NULL
for	NULL
concentrations	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

(	NULL
»	NULL
)	NULL
Unmodified	NULL
and	NULL
(	NULL
«	NULL
@	NULL
)	NULL
cleaved	NULL
NTera-2	NULL
heterodimers	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
-	NULL
b	NULL
is	NULL
U4	NULL
in	NULL
1	NULL
2	NULL
3	NULL
4	NULL
§	NULL
60	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
cathepsin	NULL
G	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
PR-3	NULL
(	NULL
39	NULL
)	NULL
,	NULL
are	NULL
highly	NULL
and	NULL
coordinately	NULL
expressed	NULL
in	NULL
myelo-monocytic	NULL
cells	NULL
only	NULL
(	NULL
50-52	NULL
)	NULL
and	NULL
that	NULL
their	NULL
expression	NULL
is	NULL
strongly	NULL
downregulated	NULL
during	NULL
terminal	NULL
differentiation	NULL
into	NULL
macrophages	NULL
or	NULL
after	NULL
TPA	NULL
treatment	NULL
of	NULL
HL-60	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
primary	NULL
monocytes	NULL
(	NULL
50-52	NULL
)	NULL
.	NULL

We	NULL
detected	NULL
by	NULL
Western	NULL
analysis	NULL
high	NULL
levels	NULL
of	NULL
cathepsin	NULL
G	NULL
in	NULL
our	NULL
HL-60	NULL
and	NULL
clone	NULL
12	NULL
cells	NULL
(	NULL
minus	NULL
)	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
in	NULL
our	NULL
THP-1	NULL
cells	NULL
,	NULL
whereas	NULL
no	NULL
such	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
clone	NULL
10	NULL
cells	NULL
(	NULL
plus	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
cathepsin	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
probe	NULL
.	NULL

G	NULL
protein	NULL
was	NULL
not	NULL
seen	NULL
in	NULL
HL-60	NULL
cells	NULL
and	NULL
clone	NULL
12	NULL
cells	NULL
after	NULL
a	NULL
5-d	NULL
treatment	NULL
with	NULL
the	NULL
differentiating	NULL
agent	NULL
TPA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
cathepsin	NULL
G	NULL
,	NULL
and	NULL
presumably	NULL
of	NULL
the	NULL
other	NULL
coordinately	NULL
expressed	NULL
proteases	NULL
(	NULL
52	NULL
)	NULL
,	NULL
correlated	NULL
with	NULL
the	NULL
presence	NULL
in	NULL
these	NULL
extracts	NULL
of	NULL
truncated	NULL
p65	NULL
forms	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
A	NULL
)	NULL
.	NULL

To	NULL
more	NULL
directly	NULL
demonstrate	NULL
a	NULL
potential	NULL
role	NULL
of	NULL
these	NULL
proteases	NULL
in	NULL
the	NULL
cleavage	NULL
of	NULL
p65	NULL
,	NULL
we	NULL
also	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
purified	NULL
elastase	NULL
and	NULL
cathepsin	NULL
G	NULL
enzymes	NULL
to	NULL
cleave	NULL
p65	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
p50-p65	NULL
heterodimers	NULL
derived	NULL
from	NULL
trans-	NULL
1450	NULL
In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL
A	NULL
Clone	NULL
10	NULL
Clone	NULL
12	NULL
[	NULL
1	NULL
I	NULL
|	NULL
0'°	NULL
5°	NULL
155	NULL
40	NULL
'	NULL
th	NULL
2h	NULL
O	NULL
'	NULL
5°	NULL
15°	NULL
40	NULL
'	NULL
1h	NULL
2h	NULL
+	NULL
>	NULL
-	NULL
W	NULL
Ww	NULL
-	NULL
“	NULL
IUIU4	NULL
C	NULL
>	NULL
U	NULL
WU	NULL
w=	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
Clone	NULL
12	NULL
HL-60	NULL
I	NULL
L	NULL
I	NULL
F	NULL
\é	NULL
@	NULL
\e	NULL
}	NULL
@	NULL
\	NULL
@	NULL
}	NULL
6\\®\	NULL
@	NULL
p6S	NULL
Ab	NULL
supershift	NULL
:	NULL
-	NULL
``	NULL
°	NULL
G	NULL
-	NULL
OC	NULL
by	NULL
:	NULL
u	NULL
“	NULL
.	NULL

Y	NULL
¥	NULL
€	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
1451	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

fected	NULL
NTera-2	NULL
cells	NULL
with	NULL
these	NULL
enzymes	NULL
generated	NULL
a	NULL
complex	NULL
still	NULL
able	NULL
to	NULL
bind	NULL
DNA	NULL
but	NULL
with	NULL
a	NULL
mobility	NULL
essentially	NULL
indistinguishable	NULL
from	NULL
that	NULL
observed	NULL
in	NULL
minus	NULL
U937	NULL
cell	NULL
clones	NULL
and	NULL
in	NULL
our	NULL
HL-60	NULL
cell	NULL
line	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
proteases	NULL
are	NULL
likely	NULL
candidates	NULL
for	NULL
the	NULL
digestion	NULL
of	NULL
p65	NULL
in	NULL
vitro	NULL
.	NULL

Discussion	NULL
This	NULL
study	NULL
demonstrates	NULL
that	NULL
a	NULL
group	NULL
of	NULL
U937	NULL
subclones	NULL
,	NULL
so-called	NULL
minus	NULL
clones	NULL
,	NULL
do	NULL
not	NULL
support	NULL
rapid	NULL
growth	NULL
of	NULL
HIV-1	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
plus	NULL
clones	NULL
,	NULL
which	NULL
allow	NULL
efficient	NULL
HIV	NULL
replication	NULL
,	NULL
minus	NULL
clones	NULL
contain	NULL
members	NULL
of	NULL
a	NULL
specific	NULL
family	NULL
of	NULL
lysosomal	NULL
serine	NULL
proteases	NULL
,	NULL
including	NULL
cathepsin	NULL
G	NULL
(	NULL
36	NULL
;	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
,	NULL
elastase	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
,	NULL
and	NULL
PR-3	NULL
(	NULL
39	NULL
)	NULL
.	NULL

These	NULL
particular	NULL
proteases	NULL
,	NULL
also	NULL
termed	NULL
serprocidins	NULL
(	NULL
53	NULL
)	NULL
,	NULL
are	NULL
released	NULL
during	NULL
cell	NULL
extraction	NULL
generating	NULL
an	NULL
apparently	NULL
novel	NULL
,	NULL
faster-migrating	NULL
NF-KB	NULL
complex	NULL
that	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
specific	NULL
truncation	NULL
of	NULL
the	NULL
COOH-terminal	NULL
part	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
.	NULL

We	NULL
demonstrate	NULL
directly	NULL
that	NULL
these	NULL
proteases	NULL
can	NULL
generate	NULL
the	NULL
modified	NULL
,	NULL
truncated	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
in	NULL
vitro	NULL
.	NULL

Expression	NULL
of	NULL
serprocidins	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
neutrophil	NULL
and	NULL
monocytic	NULL
lineages	NULL
(	NULL
50	NULL
,	NULL
52	NULL
,	NULL
54	NULL
)	NULL
and	NULL
to	NULL
certain	NULL
sublines	NULL
of	NULL
the	NULL
pro-monocytic	NULL
leukemia	NULL
cells	NULL
U937	NULL
(	NULL
minus	NULL
clones	NULL
)	NULL
,	NULL
the	NULL
pro-myelocytic	NULL
cells	NULL
HL-60	NULL
(	NULL
50	NULL
,	NULL
51	NULL
,	NULL
55	NULL
,	NULL
56	NULL
)	NULL
and	NULL
,	NULL
to	NULL
some	NULL
extent	NULL
,	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
)	NULL
.	NULL

Whereas	NULL
standard	NULL
cell	NULL
extraction	NULL
procedures	NULL
do	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
released	NULL
proteases	NULL
,	NULL
inclusion	NULL
of	NULL
specific	NULL
protease	NULL
inhibitors	NULL
does	NULL
,	NULL
thus	NULL
allowing	NULL
the	NULL
detection	NULL
of	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
even	NULL
in	NULL
the	NULL
minus	NULL
clones	NULL
and	NULL
in	NULL
the	NULL
other	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
curious	NULL
that	NULL
the	NULL
specific	NULL
truncation	NULL
of	NULL
p65	NULL
removes	NULL
all	NULL
transactivation	NULL
functions	NULL
but	NULL
none	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
functions	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
;	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Whereas	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
nontransactivating	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
might	NULL
have	NULL
offered	NULL
an	NULL
explanation	NULL
for	NULL
why	NULL
the	NULL
NF-	NULL
«	NULL
B-dependent	NULL
HIV-1	NULL
virus	NULL
did	NULL
not	NULL
grow	NULL
well	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
otherwise	NULL
,	NULL
since	NULL
the	NULL
truncation	NULL
appeared	NULL
to	NULL
occur	NULL
during	NULL
extraction	NULL
only	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
proteases	NULL
themselves	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
observed	NULL
growth	NULL
phenotype	NULL
of	NULL
HIV-1	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
investigated	NULL
NF-KB	NULL
activity	NULL
in	NULL
stimulated	NULL
myelo-monocytic	NULL
cells	NULL
,	NULL
including	NULL
U937	NULL
,	NULL
THP-1	NULL
,	NULL
HL-60	NULL
,	NULL
and	NULL
primary	NULL
monocytes	NULL
.	NULL

Revisiting	NULL
these	NULL
studies	NULL
in	NULL
light	NULL
Figure	NULL
5	NULL
.	NULL

-	NULL
Inclusion	NULL
of	NULL
DFP	NULL
in	NULL
the	NULL
extraction	NULL
buffer	NULL
allows	NULL
the	NULL
recovery	NULL
of	NULL
the	NULL
full-length	NULL
p65	NULL
subunit	NULL
.	NULL

(	NULL
4	NULL
)	NULL
EMSA	NULL
performed	NULL
with	NULL
extracts	NULL
of	NULL
U937	NULL
clone	NULL
10	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
and	NULL
clone	NULL
12	NULL
(	NULL
lanes	NULL
7-12	NULL
)	NULL
cells	NULL
collected	NULL
at	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
after	NULL
TNF-o	NULL
stimulation	NULL
.	NULL

For	NULL
this	NULL
experiment	NULL
,	NULL
cells	NULL
were	NULL
extracted	NULL
in	NULL
a	NULL
modified	NULL
lysis	NULL
buffer	NULL
containing	NULL
the	NULL
protease	NULL
inhibitor	NULL
DFP	NULL
(	NULL
30	NULL
mM	NULL
;	NULL
for	NULL
details	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

(	NULL
t	NULL
>	NULL
)	NULL
p50	NULL
and	NULL
(	NULL
¥	NULL
,	NULL
«	NULL
@	NULL
)	NULL
p50-p65	NULL
heterodimers	NULL
.	NULL

An	NULL
equivalent	NULL
amount	NULL
of	NULL
extract	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Supershift	NULL
analysis	NULL
performed	NULL
on	NULL
extracts	NULL
made	NULL
(	NULL
as	NULL
described	NULL
above	NULL
)	NULL
from	NULL
clone	NULL
12	NULL
and	NULL
HL-60	NULL
cells	NULL
(	NULL
lanes	NULL
1-3	NULL
and	NULL
4-6	NULL
,	NULL
respectively	NULL
)	NULL
treated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
TNF-	NULL
,	NULL
by	NULL
using	NULL
antibodies	NULL
directed	NULL
to	NULL
an	NULL
NH	NULL
;	NULL
-terminal	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
as	NULL
well	NULL
as	NULL
to	NULL
a	NULL
COOH-terminal	NULL
p65	NULL
peptide	NULL
sequence	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

(	NULL
[	NULL
>	NULL
)	NULL
p50-p50	NULL
and	NULL
(	NULL
W	NULL
»	NULL
)	NULL
p50-p65	NULL
band	NULL
shift	NULL
;	NULL
and	NULL
(	NULL
@	NULL
)	NULL
supershifts	NULL
.	NULL

The	NULL
residual	NULL
binding	NULL
activity	NULL
seen	NULL
with	NULL
both	NULL
anti-p65	NULL
antibodies	NULL
was	NULL
due	NULL
either	NULL
to	NULL
p50	NULL
homodimers	NULL
or	NULL
to	NULL
c-Rel-p50	NULL
heterodimers	NULL
(	NULL
*	NULL
)	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
use	NULL
of	NULL
specific	NULL
antibodies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
the	NULL
PD-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

HL-60	NULL
Clone	NULL
12	NULL
_	NULL
C1	NULL
.	NULL

10	NULL
THP-1	NULL
monocytes	NULL
I	NULL
1	NULL
I	NULL
1	NULL
4	NULL
1	NULL
I	NULL
1	NULL
I	NULL
p	NULL
B	NULL
&	NULL
C	NULL
&	NULL
6x	NULL
C	NULL
o	NULL
$	NULL
£	NULL
4	NULL
C	NULL
3	NULL
«	NULL
~	NULL
a	NULL
$	NULL
*	NULL
o	NULL
oa	NULL
X	NULL
treatment	NULL
:	NULL
-_	NULL
<	NULL
<	NULL
9	NULL
ils	NULL
-	NULL
A	NULL
&	NULL
-	NULL
-	NULL
_C	NULL
o	NULL
3	NULL
&	NULL
feal	NULL
Cb	NULL
ditt	NULL
aas	NULL
-	NULL
>	NULL
Ge	NULL
«	NULL
a	NULL
»	NULL
«	NULL
in	NULL
«	NULL
in	NULL
«	NULL
am	NULL
1°	NULL
2	NULL
0	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
8	NULL
95	NULL
HLso	NULL
-	NULL
clr	NULL
&	NULL
<	NULL
TPA	NULL
treatment	NULL
:	NULL
|	NULL
-	NULL
4	NULL
-	NULL
$	NULL
0	NULL
-	NULL
=	NULL
Figure	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
cathepsin	NULL
G	NULL
,	NULL
and	NULL
presumably	NULL
of	NULL
related	NULL
serine	NULL
proteases	NULL
,	NULL
correlates	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
truncated	NULL
forms	NULL
of	NULL
p65	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Truncated	NULL
p65	NULL
forms	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
extracts	NULL
made	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
myelo-monocytic	NULL
cells	NULL
and	NULL
the	NULL
full-length	NULL
p65	NULL
subunit	NULL
is	NULL
restored	NULL
after	NULL
treatment	NULL
with	NULL
differentiating	NULL
agents	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
,	NULL
obtained	NULL
(	NULL
in	NULL
absence	NULL
of	NULL
DFP	NULL
)	NULL
from	NULL
HI-60	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
,	NULL
U937	NULL
clone	NULL
12	NULL
and	NULL
10	NULL
(	NULL
lanes	NULL
6-7	NULL
and	NULL
8	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
cells	NULL
and	NULL
primary	NULL
monocytes	NULL
(	NULL
lanes	NULL
10-14	NULL
)	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
followed	NULL
by	NULL
Western	NULL
blot	NULL
performed	NULL
with	NULL
a	NULL
p65	NULL
mouse	NULL
antibody	NULL
,	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
6	NULL
,	NULL
$	NULL
10	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
HL-60	NULL
,	NULL
lane	NULL
5	NULL
;	NULL
Clone	NULL
12	NULL
,	NULL
lane	NULL
7	NULL
;	NULL
primary	NULL
monocytes	NULL
,	NULL
lane	NULL
14	NULL
)	NULL
or	NULL
other	NULL
differentiating	NULL
agents	NULL
,	NULL
as	NULL
indicated	NULL
{	NULL
for	NULL
details	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

{	NULL
»	NULL
)	NULL
Full-length	NULL
and	NULL
{	NULL
|	NULL
)	NULL
truncated	NULL
p65	NULL
species	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
presence	NULL
of	NULL
cathepsin	NULL
G	NULL
correlates	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
truncated	NULL
p65	NULL
species	NULL
.	NULL

Western	NULL
blot	NULL
performed	NULL
on	NULL
the	NULL
same	NULL
extracts	NULL
used	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
,	NULL
with	NULL
an	NULL
anti-cathepsin	NULL
G	NULL
polyclonal	NULL
antibody	NULL
(	NULL
Calbiochem-Novabiochem	NULL
Corp.	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
used	NULL
as	NULL
indicated	NULL
and	NULL
normalized	NULL
for	NULL
protein	NULL
concentration	NULL
.	NULL

The	NULL
detection	NULL
of	NULL
multiple	NULL
cathepsin	NULL
G	NULL
specific	NULL
bands	NULL
{	NULL
|	NULL
}	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
glycosyla-	NULL
tion	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

of	NULL
our	NULL
data	NULL
suggests	NULL
that	NULL
in	NULL
at	NULL
least	NULL
several	NULL
cases	NULL
the	NULL
abnormal	NULL
,	NULL
__	NULL
restricted	NULL
in	NULL
supporting	NULL
the	NULL
growth	NULL
of	NULL
HIV	NULL
.	NULL

The	NULL
authors	NULL
con-faster-migrating	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
may	NULL
have	NULL
been	NULL
present	NULL
,	NULL
_	NULL
cluded	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
somehow	NULL
inhibited	NULL
in	NULL
these	NULL
rather	NULL
than	NULL
the	NULL
normal	NULL
one	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
34	NULL
,	NULL
57-63	NULL
)	NULL
.	NULL

This	NULL
includes	NULL
_	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
another	NULL
laboratory	NULL
has	NULL
noted	NULL
an	NULL
unusual	NULL
,	NULL
faster-the	NULL
case	NULL
of	NULL
the	NULL
chronically	NULL
HIV-infected	NULL
U1	NULL
cells	NULL
,	NULL
a	NULL
deriva-	NULL
_	NULL
migrating	NULL
NF-KB	NULL
complex	NULL
upon	NULL
induction	NULL
of	NULL
primary	NULL
mono-tive	NULL
of	NULL
U937	NULL
cells	NULL
(	NULL
64	NULL
,	NULL
65	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
one	NULL
report	NULL
(	NULL
34	NULL
)	NULL
noted	NULL
_	NULL
cytic	NULL
cells	NULL
(	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
S.	NULL
Haskill	NULL
,	NULL
personal	NULL
communi-the	NULL
absence	NULL
of	NULL
normal	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
those	NULL
THP-1	NULL
cells	NULL
that	NULL
were	NULL
_	NULL
cation	NULL
)	NULL
.	NULL

An	NULL
unusual	NULL
,	NULL
faster-migrating	NULL
NF-KB	NULL
complex	NULL
has	NULL
1452	NULL
In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL
x	NULL
(	NULL
gee	NULL
(	NULL
5ch	NULL
&	NULL
C	NULL
protease	NULL
:	NULL
-	NULL
G	NULL
@	NULL
``	NULL
Figure	NULL
7	NULL
.	NULL

Cathepsin	NULL
G	NULL
and	NULL
neutrophil	NULL
elastase	NULL
convert	NULL
a	NULL
normally	NULL
migrating	NULL
p50-p65	NULL
hetero-	NULL
.	NULL

dimer	NULL
into	NULL
a	NULL
faster-migrating	NULL
one	NULL
,	NULL
in	NULL
vitro	NULL
.	NULL

EMSA	NULL
performed	NULL
with	NULL
extracts	NULL
obtained	NULL
from	NULL
NTera-2	NULL
cells	NULL
transfected	NULL
with	NULL
p50	NULL
and	NULL
p65	NULL
vectors	NULL
(	NULL
see	NULL
-	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
and	NULL
preincubated	NULL
with	NULL
30	NULL
ng	NULL
of	NULL
purified	NULL
elastase	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
cathepsin	NULL
G	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
before	NULL
adding	NULL
the	NULL
PD-KB	NULL
probe	NULL
.	NULL

(	NULL
[	NULL
>	NULL
)	NULL
p50	NULL
homodimer	NULL
and	NULL
(	NULL
»	NULL
)	NULL
p50-p65	NULL
het-erodimer	NULL
bands	NULL
;	NULL
(	NULL
@	NULL
)	NULL
migration	NULL
of	NULL
the	NULL
-	NULL
digested	NULL
-	NULL
heterodimeric	NULL
complex	NULL
.	NULL

D	NULL
[	NULL
>	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
regenerating	NULL
liver	NULL
cells	NULL
(	NULL
66	NULL
)	NULL
.	NULL

Since	NULL
liver	NULL
contains	NULL
cells	NULL
of	NULL
myelo-monocytic	NULL
origin	NULL
as	NULL
well	NULL
as	NULL
high	NULL
levels	NULL
of	NULL
various	NULL
serine	NULL
proteases	NULL
(	NULL
67-69	NULL
)	NULL
and	NULL
since	NULL
liver	NULL
can	NULL
be	NULL
rapidly	NULL
infiltrated	NULL
with	NULL
circulating	NULL
neutrophils	NULL
(	NULL
70	NULL
,	NULL
71	NULL
)	NULL
this	NULL
complex	NULL
may	NULL
also	NULL
have	NULL
been	NULL
generated	NULL
by	NULL
proteolytic	NULL
digestion	NULL
in	NULL
vitro	NULL
.	NULL

However	NULL
,	NULL
this	NULL
has	NULL
not	NULL
been	NULL
experimentally	NULL
tested	NULL
by	NULL
us	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
extraction	NULL
procedures	NULL
employed	NULL
in	NULL
each	NULL
of	NULL
the	NULL
instances	NULL
listed	NULL
above	NULL
would	NULL
not	NULL
be	NULL
expected	NULL
to	NULL
inhibit	NULL
the	NULL
specific	NULL
proteases	NULL
that	NULL
process	NULL
p65	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
special	NULL
precautions	NULL
must	NULL
be	NULL
taken	NULL
when	NULL
preparing	NULL
extracts	NULL
from	NULL
any	NULL
cells	NULL
of	NULL
the	NULL
myelo-monocytic	NULL
lineage	NULL
,	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
this	NULL
class	NULL
of	NULL
proteases	NULL
in	NULL
certain	NULL
cell	NULL
sublines	NULL
or	NULL
primary	NULL
cell	NULL
mixtures	NULL
.	NULL

In	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
,	NULL
serprocidins	NULL
are	NULL
contained	NULL
within	NULL
specialized	NULL
lysosomes	NULL
,	NULL
termed	NULL
azurophil	NULL
granules	NULL
(	NULL
72	NULL
)	NULL
and	NULL
perform	NULL
important	NULL
antimicrobial	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
the	NULL
killing	NULL
of	NULL
phagocytosed	NULL
microorganisms	NULL
(	NULL
53	NULL
,	NULL
73	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
to	NULL
this	NULL
described	NULL
role	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
serprocidins	NULL
(	NULL
present	NULL
only	NULL
in	NULL
the	NULL
nonpermis-sive	NULL
minus	NULL
clones	NULL
)	NULL
may	NULL
negatively	NULL
affect	NULL
the	NULL
life	NULL
cycle	NULL
of	NULL
HIV-1	NULL
in	NULL
U937	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
other	NULL
monocytic	NULL
cells	NULL
such	NULL
as	NULL
THP-1	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
such	NULL
proteases	NULL
in	NULL
circulating	NULL
mono	NULL
cytes	NULL
could	NULL
also	NULL
explain	NULL
the	NULL
low	NULL
viral	NULL
burden	NULL
associated	NULL
with	NULL
these	NULL
cells	NULL
in	NULL
HIV-infected	NULL
individuals	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
28	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
monocytes	NULL
in	NULL
vitro	NULL
with	NULL
differentiating	NULL
agents	NULL
,	NULL
such	NULL
as	NULL
GM-CSF	NULL
and	NULL
IFN-y	NULL
,	NULL
however	NULL
,	NULL
greatly	NULL
enhance	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
in	NULL
vitro	NULL
(	NULL
26-31	NULL
)	NULL
.	NULL

This	NULL
is	NULL
of	NULL
interest	NULL
since	NULL
expression	NULL
of	NULL
elastase	NULL
,	NULL
cathepsin	NULL
G	NULL
,	NULL
and	NULL
PR-3	NULL
genes	NULL
is	NULL
coordinately	NULL
dow	NULL
nmodulated	NULL
by	NULL
TPA	NULL
(	NULL
50	NULL
,	NULL
52	NULL
,	NULL
55	NULL
,	NULL
56	NULL
)	NULL
,	NULL
GM-CSF	NULL
,	NULL
IFN-y	NULL
,	NULL
or	NULL
other	NULL
agents	NULL
that	NULL
promote	NULL
differentiation	NULL
of	NULL
monocytic	NULL
and	NULL
HL-60	NULL
cells	NULL
into	NULL
macrophages	NULL
(	NULL
See	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
their	NULL
expression	NULL
increases	NULL
in	NULL
HL-60	NULL
after	NULL
treatment	NULL
with	NULL
DMSO	NULL
,	NULL
an	NULL
agent	NULL
that	NULL
differentiates	NULL
these	NULL
cells	NULL
into	NULL
granulocytes	NULL
(	NULL
49	NULL
,	NULL
50	NULL
,	NULL
74	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
our	NULL
U937	NULL
plus	NULL
clones	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
serprocidins	NULL
seems	NULL
not	NULL
to	NULL
be	NULL
strictly	NULL
correlated	NULL
with	NULL
terminal	NULL
differentiation	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
differentiated	NULL
phenotype	NULL
or	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
proliferation	NULL
rate	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Another	NULL
possible	NULL
explanation	NULL
of	NULL
the	NULL
poor	NULL
growth	NULL
of	NULL
HIV	NULL
in	NULL
minus	NULL
clones	NULL
is	NULL
that	NULL
whereas	NULL
serprocidins	NULL
may	NULL
not	NULL
themselves	NULL
be	NULL
directly	NULL
retarding	NULL
HIV-1	NULL
replication	NULL
,	NULL
they	NULL
are	NULL
induced	NULL
coincidently	NULL
with	NULL
some	NULL
other	NULL
protein	NULL
which	NULL
is	NULL
the	NULL
effector	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
process	NULL
which	NULL
positively	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
serprocidins	NULL
may	NULL
also	NULL
negatively	NULL
regulate	NULL
HIV-1	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
this	NULL
latter	NULL
possibility	NULL
seems	NULL
unlikely	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
both	NULL
minus	NULL
and	NULL
plus	NULL
clones	NULL
contain	NULL
normal	NULL
p50-p65	NULL
heterodimers	NULL
that	NULL
are	NULL
essential	NULL
to	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
HIV-LTR	NULL
.	NULL

These	NULL
complexes	NULL
are	NULL
functional	NULL
in	NULL
both	NULL
minus	NULL
and	NULL
plus	NULL
cell	NULL
types	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
the	NULL
strong	NULL
induction	NULL
of	NULL
I	NULL
«	NULL
B-a	NULL
synthesis	NULL
after	NULL
TNF-a	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
;	NULL
see	NULL
Results	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
transcriptional	NULL
defect	NULL
affecting	NULL
the	NULL
HIV-LTR	NULL
in	NULL
minus	NULL
clones	NULL
is	NULL
inconsistent	NULL
with	NULL
previous	NULL
data	NULL
on	NULL
the	NULL
chronically	NULL
infected	NULL
U937	NULL
cell	NULL
line	NULL
U1	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
U1	NULL
cells	NULL
have	NULL
a	NULL
minus	NULL
phenotype	NULL
and	NULL
their	NULL
extracts	NULL
contain	NULL
the	NULL
truncated	NULL
NF-KB	NULL
complex	NULL
(	NULL
64	NULL
,	NULL
65	NULL
;	NULL
G.	NULL
Poli	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
causes	NULL
rapid	NULL
production	NULL
of	NULL
HIV-RNA	NULL
and	NULL
virions	NULL
(	NULL
75-77	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
impaired	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
U937	NULL
minus	NULL
clones	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
due	NULL
to	NULL
events	NULL
preceding	NULL
or	NULL
coincident	NULL
with	NULL
HIV	NULL
integration	NULL
.	NULL

Whether	NULL
early	NULL
events	NULL
during	NULL
HIV	NULL
replication	NULL
are	NULL
affected	NULL
directly	NULL
or	NULL
indirectly	NULL
by	NULL
the	NULL
specific	NULL
serine	NULL
proteases	NULL
discussed	NULL
here	NULL
is	NULL
under	NULL
investigation	NULL
.	NULL

We	NULL
thank	NULL
N.	NULL
Rice	NULL
for	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
the	NULL
p65	NULL
antibodies	NULL
.	NULL

We	NULL
are	NULL
also	NULL
grateful	NULL
to	NULL
M.	NULL
Rust	NULL
for	NULL
help	NULL
with	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

P.	NULL
Biswas	NULL
is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanité	NULL
(	NULL
ISS	NULL
)	NULL
,	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

ISS	NULL
partly	NULL
financed	NULL
this	NULL
project	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Dr.	NULL
U.	NULL
K.	NULL
Siebenlist	NULL
,	NULL
Laboratory	NULL
of	NULL
Immunoregulation	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Infectious	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
11B-13	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
.	NULL

G.	NULL
Franzoso	NULL
is	NULL
on	NULL
leave	NULL
from	NULL
Servizio	NULL
Di	NULL
Microbiologia	NULL
,	NULL
Complesso	NULL
Convenzionato	NULL
Université-ULSS	NULL
21	NULL
,	NULL
Via	NULL
Ospedale	NULL
2	NULL
,	NULL
35100	NULL
Padua	NULL
,	NULL
Italy	NULL
.	NULL

G.	NULL
Poli	NULL
's	NULL
present	NULL
address	NULL
is	NULL
AIDS	NULL
Immunopathogenesis	NULL
Unit	NULL
,	NULL
Divisione	NULL
di	NULL
Malattie	NULL
Infettive	NULL
,	NULL
Istituto	NULL
Scientifico	NULL
San	NULL
Raffaele	NULL
,	NULL
Via	NULL
Stamira	NULL
d'Ancona	NULL
n.20	NULL
,	NULL
20127	NULL
Milan	NULL
,	NULL
Italy	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
1	NULL
April	NULL
1994	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
29	NULL
June	NULL
1994	NULL
.	NULL

1453	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

References	NULL
1	NULL
.	NULL

2	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
T.	NULL
Henkel	NULL
.	NULL

1994	NULL
.	NULL

Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:141	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
J.J.S	NULL
.	NULL

Chiu	NULL
,	NULL
and	NULL
M.J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
Rel	NULL
:	NULL
participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

148:1.	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IKB-a	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

90:2532.	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
PA.	NULL
Ganchi	NULL
,	NULL
DW	NULL
.	NULL

Ballard	NULL
,	NULL
and	NULL
W.C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
I	NULL
«	NULL
B-ax	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

259:1912.	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siecbenlist	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bcl-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
p50/NF-	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

359:339.	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
V.	NULL
Azarenko	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-	NULL
Yamaguchi	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
oncoprotein	NULL
Bel-3	NULL
can	NULL
facilitate	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transactivation	NULL
by	NULL
removing	NULL
inhibiting	NULL
p50	NULL
homodimers	NULL
from	NULL
select	NULL
«	NULL
B	NULL
sites	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:3893.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
PR	NULL
.	NULL

Burd	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
R.	NULL
Ryseck	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50-p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685.	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
V.	NULL
Azarenko	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Sicbenlist	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
oncoprotein	NULL
Bel-3	NULL
directly	NULL
transactivates	NULL
through	NULL
kB	NULL
motifs	NULL
via	NULL
association	NULL
with	NULL
DNA-binding	NULL
p50B	NULL
homodimers	NULL
.	NULL

Cell	NULL
.	NULL

72:729.	NULL
.	NULL

Griffin	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
K.	NULL
Leung	NULL
,	NULL
TM	NULL
.	NULL

Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.J	NULL
.	NULL

Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

339:70	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Arenzana-Seisdedos	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1991	NULL
.	NULL

HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

350:709	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

335:783	NULL
.	NULL

Bellas	NULL
,	NULL
R.E	NULL
.	NULL

,	NULL
N.	NULL
Hopkins	NULL
,	NULL
and	NULL
Y.	NULL
Li	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-KB	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
efficient	NULL
replication	NULL
of	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
of	NULL
macaques	NULL
in	NULL
primary	NULL
macrophages	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2908	NULL
.	NULL

Laurence	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Reservoirs	NULL
of	NULL
HIV	NULL
infection	NULL
or	NULL
carriage	NULL
:	NULL
monocytic	NULL
,	NULL
dendritic	NULL
,	NULL
follicular	NULL
dendritic	NULL
,	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Ann	NULL
.	NULL

N.Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

693:52	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
role	NULL
of	NULL
monocyte/macro-phages	NULL
and	NULL
cytokines	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Pathobiology	NULL
.	NULL

60:246	NULL
.	NULL

Kalter	NULL
,	NULL
D.C.	NULL
,	NULL
H.E	NULL
.	NULL

Gendelman	NULL
,	NULL
and	NULL
M.S	NULL
.	NULL

Meltzer	NULL
.	NULL

1991	NULL
.	NULL

Monocytes	NULL
,	NULL
dendritic	NULL
cells	NULL
,	NULL
and	NULL
langerhans	NULL
cells	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
.	NULL

Dermatologic	NULL
Clinics	NULL
.	NULL

9:415	NULL
.	NULL

Rappersberger	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Gartner	NULL
,	NULL
P.	NULL
Schenk	NULL
,	NULL
G.	NULL
Stingl	NULL
,	NULL
V.	NULL
Groh	NULL
,	NULL
E.	NULL
Tschachler	NULL
,	NULL
D.L	NULL
.	NULL

Mann	NULL
,	NULL
K.	NULL
Wolff	NULL
,	NULL
K.	NULL
Donrad	NULL
,	NULL
and	NULL
M.	NULL
Popovic	NULL
.	NULL

1988	NULL
.	NULL

Langerhans	NULL
cells	NULL
are	NULL
an	NULL
actual	NULL
site	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

Intervirology	NULL
.	NULL

29:185	NULL
.	NULL

Embretson	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Zupancic	NULL
,	NULL
J.L	NULL
.	NULL

Ribas	NULL
,	NULL
A.	NULL
Burke	NULL
,	NULL
P.	NULL
Racz	NULL
,	NULL
K.	NULL
Tenenr-Racz	NULL
,	NULL
and	NULL
A.	NULL
Haase	NULL
.	NULL

1993	NULL
.	NULL

Massive	NULL
covert	NULL
infection	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
and	NULL
macrophages	NULL
by	NULL
HIV	NULL
during	NULL
the	NULL
incubation	NULL
period	NULL
of	NULL
AIDS	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

362:359	NULL
.	NULL

Koenig	NULL
,	NULL
S.	NULL
,	NULL
H.E	NULL
.	NULL

Gendelman	NULL
,	NULL
J.M	NULL
.	NULL

Orenstein	NULL
,	NULL
M.C	NULL
.	NULL

DalCanto	NULL
,	NULL
G.H	NULL
.	NULL

Pezeshkpour	NULL
,	NULL
P.	NULL
Yungbluth	NULL
,	NULL
F.	NULL
Jannotta	NULL
,	NULL
A.	NULL
Aksamit	NULL
,	NULL
M.A	NULL
.	NULL

Martin	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1986	NULL
.	NULL

Detection	NULL
of	NULL
AIDS	NULL
virus	NULL
1454	NULL
19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33.	NULL
in	NULL
macrophages	NULL
in	NULL
brain	NULL
tissue	NULL
from	NULL
AIDS	NULL
patients	NULL
with	NULL
en-cephalopathy	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

233:1089	NULL
.	NULL

Stoler	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
T.A	NULL
.	NULL

Eskin	NULL
,	NULL
and	NULL
S.	NULL
Benn	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotrophic	NULL
virus	NULL
type	NULL
III	NULL
infection	NULL
of	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
:	NULL
preliminary	NULL
in	NULL
sity	NULL
analysis	NULL
.	NULL

JAMA	NULL
(	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL
)	NULL

.	NULL

256:2360	NULL
.	NULL

Gartner	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Markovits	NULL
,	NULL
D.M	NULL
.	NULL

Markovitz	NULL
,	NULL
M.H	NULL
.	NULL

Kaplan	NULL
,	NULL
R.C	NULL
.	NULL

Gallo	NULL
,	NULL
and	NULL
M.	NULL
Popovic	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
role	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
HTIV/LAV	NULL
infection	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

233:215	NULL
.	NULL

Salahuddin	NULL
,	NULL
$	NULL
.Z	NULL
.	NULL

,	NULL
R.M	NULL
.	NULL

Rose	NULL
,	NULL
J.E	NULL
.	NULL

Groopman	NULL
,	NULL
P.D	NULL
.	NULL

Markham	NULL
,	NULL
and	NULL
R.C	NULL
.	NULL

Gallo	NULL
.	NULL

1986	NULL
.	NULL

Human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
III	NULL
infection	NULL
of	NULL
human	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Blood	NULL
.	NULL

68:281	NULL
.	NULL

McElrath	NULL
,	NULL
M.J.	NULL
,	NULL
J.E	NULL
.	NULL

Pruett	NULL
,	NULL
and	NULL
Z.A	NULL
.	NULL

Cohn	NULL
.	NULL

1989	NULL
.	NULL

Mononuclear	NULL
phagocytes	NULL
of	NULL
blood	NULL
and	NULL
bone	NULL
marrow	NULL
:	NULL
comparative	NULL
roles	NULL
as	NULL
viral	NULL
reservoirs	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infections	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:675	NULL
.	NULL

Innocenti	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Ottman	NULL
,	NULL
O.	NULL
Morand	NULL
,	NULL
P.	NULL
Leclercq	NULL
,	NULL
and	NULL
J.	NULL
Seig-neurin	NULL
.	NULL

1992	NULL
.	NULL

HIV-1	NULL
in	NULL
blood	NULL
monocytes	NULL
:	NULL
frequency	NULL
of	NULL
detection	NULL
of	NULL
proviral	NULL
DNA	NULL
using	NULL
PCR	NULL
and	NULL
comparison	NULL
with	NULL
the	NULL
total	NULL
CD4	NULL
count	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
,	NULL
8:261	NULL
.	NULL

Schnittman	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
M.C	NULL
.	NULL

Psalidopoulos	NULL
,	NULL
H.C.	NULL
Lane	NULL
,	NULL
L.	NULL
Thompson	NULL
,	NULL
M.	NULL
Baseler	NULL
,	NULL
F.	NULL
Massari	NULL
,	NULL
C.H	NULL
.	NULL

Fox	NULL
,	NULL
N.P	NULL
.	NULL

Salzman	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
reservoir	NULL
for	NULL
HIV-1	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
is	NULL
a	NULL
T	NULL
cell	NULL
that	NULL
maintains	NULL
expression	NULL
of	NULL
CD4	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

245	NULL
;	NULL
305	NULL
.	NULL

Spear	NULL
,	NULL
GI	NULL
.	NULL

,	NULL
O.	NULL
ChinYih	NULL
,	NULL
H.A	NULL
.	NULL

Kessler	NULL
,	NULL
J.C.	NULL
Moore	NULL
,	NULL
G.	NULL
Schochetman	NULL
,	NULL
and	NULL
A.L	NULL
.	NULL

Landay	NULL
.	NULL

1990	NULL
.	NULL

Analysis	NULL
of	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
neutrophils	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infected	NULL
persons	NULL
for	NULL
HIV	NULL
DNA	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

162:1239	NULL
.	NULL

Gendelman	NULL
,	NULL
H.E	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

Orenstein	NULL
,	NULL
M.A	NULL
.	NULL

Martin	NULL
,	NULL
C.	NULL
Ferrua	NULL
,	NULL
R.	NULL
Mitra	NULL
,	NULL
T.	NULL
Phipps	NULL
,	NULL
L.A.	NULL
Wahl	NULL
,	NULL
H.C.	NULL
Lane	NULL
,	NULL
A.S.	NULL
Fauci	NULL
,	NULL
D.S	NULL
.	NULL

Burke	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
.	NULL

Efficient	NULL
isolation	NULL
and	NULL
propagation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
on	NULL
recombinant	NULL
colony-stimulating	NULL
factor	NULL
1-treated	NULL
monocytes	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

167:1428	NULL
.	NULL

Perno	NULL
,	NULL
C.-F.	NULL
,	NULL
R.	NULL
Yarchoan	NULL
,	NULL
D.A	NULL
.	NULL

Cooney	NULL
,	NULL
N.R	NULL
.	NULL

Hartman	NULL
,	NULL
D.S.A	NULL
.	NULL

Webb	NULL
,	NULL
Z.	NULL
Hao	NULL
,	NULL
H.	NULL
Mitsuya	NULL
,	NULL
D.G	NULL
.	NULL

Johns	NULL
,	NULL
and	NULL
S.	NULL
Broder	NULL
.	NULL

1989	NULL
.	NULL

Replication	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
monocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:933	NULL
.	NULL

Folks	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
C.	NULL
A.	NULL
Dinarello	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1987	NULL
.	NULL

Cytokine-induced	NULL
expression	NULL
of	NULL
HIV-1	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
promonocyte	NULL
cell	NULL
line	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

238:800	NULL
.	NULL

Koyanagi	NULL
,	NULL
Y.	NULL
,	NULL
W.A	NULL
.	NULL

O'Brien	NULL
,	NULL
J.Q	NULL
.	NULL

Zhao	NULL
,	NULL
DW	NULL
.	NULL

Golde	NULL
,	NULL
J.C.	NULL
Gasson	NULL
,	NULL
and	NULL
I.S	NULL
.	NULL

Chen	NULL
.	NULL

1988	NULL
.	NULL

Cytokines	NULL
alter	NULL
production	NULL
of	NULL
HIV-1	NULL
from	NULL
primary	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

241:1673	NULL
.	NULL

Kitano	NULL
,	NULL
K.	NULL
,	NULL
G.C	NULL
.	NULL

Baldwin	NULL
,	NULL
M.A	NULL
.	NULL

Raines	NULL
,	NULL
and	NULL
DW	NULL
.	NULL

Golde	NULL
.	NULL

1990	NULL
.	NULL

Differentiating	NULL
agents	NULL
facilitate	NULL
infection	NULL
of	NULL
myeloid	NULL
leukemia	NULL
cell	NULL
lines	NULL
by	NULL
monocytotropic	NULL
HIV-1	NULL
strains	NULL
.	NULL

Blood	NULL
.	NULL

76:1980	NULL
.	NULL

Schuitemaker	NULL
,	NULL
H.	NULL
,	NULL
N.A	NULL
.	NULL

Kootstra	NULL
,	NULL
M.H.G.M	NULL
.	NULL

Koppelman	NULL
,	NULL
S	NULL
$	NULL
.M	NULL
.	NULL

Bruisten	NULL
,	NULL
H.G	NULL
.	NULL

Husiman	NULL
,	NULL
M.	NULL
Tersmette	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
.	NULL

1992	NULL
.	NULL

Proliferation-dependent	NULL
HIV-1	NULL
infection	NULL
of	NULL
monocytes	NULL
occurs	NULL
during	NULL
differentiation	NULL
into	NULL
macrophages	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
,	NULL
89:1154	NULL
.	NULL

Meltzer	NULL
,	NULL
M.S	NULL
.	NULL

,	NULL
D.R	NULL
.	NULL

Skillman	NULL
,	NULL
D.L	NULL
.	NULL

Hoover	NULL
,	NULL
B.D	NULL
.	NULL

Hanson	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Turpin	NULL
,	NULL
D.C.	NULL
Kalter	NULL
,	NULL
and	NULL
H.E	NULL
.	NULL

Gendelman	NULL
.	NULL

1990	NULL
.	NULL

Macrophages	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

11:217	NULL
.	NULL

Boulerice	NULL
,	NULL
F.	NULL
,	NULL
R.	NULL
Geleziunas	NULL
,	NULL
S.	NULL
Bour	NULL
,	NULL
H.	NULL
Li	NULL
,	NULL
M.	NULL
D'Addario	NULL
,	NULL
A.	NULL
Roulston	NULL
,	NULL
J.	NULL
Hiscott	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Wainberg	NULL
.	NULL

1992	NULL
.	NULL

Differential	NULL
susceptibilities	NULL
of	NULL
U-937	NULL
cell	NULL
clones	NULL
to	NULL
infection	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:1183	NULL
.	NULL

In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
kB/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

Raziuddin	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Mikovits	NULL
,	NULL
I.	NULL
Calvert	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-F.	NULL
,	NULL
King	NULL
,	NULL
and	NULL
FEW	NULL
.	NULL

Ruscetti	NULL
.	NULL

1991	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
in	NULL
monocytes	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
65-kDa	NULL
plus	NULL
50-kDa	NULL
NF-KB	NULL
dimer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:9426	NULL
.	NULL

Mikovits	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Raziuddin	NULL
,	NULL
M.	NULL
Gonda	NULL
,	NULL
M.	NULL
Ruta	NULL
,	NULL
N.C.	NULL
Lohrey	NULL
,	NULL
H.-F.	NULL
Kung	NULL
,	NULL
and	NULL
FEW	NULL
.	NULL

Ruscetti	NULL
.	NULL

1990	NULL
.	NULL

Negative	NULL
regulation	NULL
of	NULL
human	NULL
immune	NULL
deficiency	NULL
virus	NULL
replication	NULL
in	NULL
monocytes	NULL
.	NULL

Distinctions	NULL
between	NULL
restricted	NULL
and	NULL
latent	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

171:1705	NULL
.	NULL

Salvesen	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
Farley	NULL
,	NULL
J.	NULL
Shuman	NULL
,	NULL
A.	NULL
Przybyla	NULL
,	NULL
C.	NULL
Reilly	NULL
,	NULL
and	NULL
J.	NULL
Travis	NULL
.	NULL

1987	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
human	NULL
cathepsin	NULL
G	NULL
:	NULL
structural	NULL
similarity	NULL
to	NULL
mast	NULL
cell	NULL
and	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
proteinases	NULL
.	NULL

Biochemistry	NULL
.	NULL

26:2289	NULL
.	NULL

Farley	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Salvesen	NULL
,	NULL
and	NULL
J.	NULL
Travis	NULL
.	NULL

1988	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
human	NULL
neutrophil	NULL
elastase	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

Hoppe-Seyler	NULL
.	NULL

369	NULL
(	NULL
Suppl	NULL
)	NULL
:	NULL
3	NULL
.	NULL

Takahashi	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Nukiwa	NULL
,	NULL
K.	NULL
Yoshimura	NULL
,	NULL
C.D	NULL
.	NULL

Quick	NULL
,	NULL
DJ	NULL
.	NULL

States	NULL
,	NULL
M.D	NULL
.	NULL

Holmes	NULL
,	NULL
J.	NULL
Whang-Peng	NULL
,	NULL
T.	NULL
Knutsen	NULL
,	NULL
and	NULL
RG	NULL
.	NULL

Crystal	NULL
.	NULL

1988	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
neutrophil	NULL
elastase	NULL
gene	NULL
.	NULL

_J	NULL
.	NULL

Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:14739	NULL
.	NULL

Rao	NULL
,	NULL
NV	NULL
.	NULL

,	NULL
N.G	NULL
.	NULL

Wehner	NULL
,	NULL
BC	NULL
.	NULL

Marshall	NULL
,	NULL
W.R.	NULL
Gray	NULL
,	NULL
BH	NULL
.	NULL

Gray	NULL
,	NULL
and	NULL
J.H	NULL
.	NULL

Hoidal	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
proteinase-3	NULL
(	NULL
PR-3	NULL
)	NULL
,	NULL
a	NULL
neutrophil	NULL
serine	NULL
proteinase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9540	NULL
.	NULL

Biswas	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
J.M	NULL
.	NULL

Orenstein	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1994	NULL
.	NULL

Cytokine-mediated	NULL
induction	NULL
of	NULL
HIV	NULL
expression	NULL
and	NULL
cell	NULL
death	NULL
in	NULL
chronically	NULL
infected	NULL
U1	NULL
cells	NULL
.	NULL

Do	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
and	NULL
interferon-gamma	NULL
selectively	NULL
kill	NULL
HIV	NULL
infected	NULL
cells	NULL
?	NULL

J.	NULL
Virol	NULL
.	NULL

68:2598	NULL
.	NULL

Figdot	NULL
,	NULL
C.G	NULL
.	NULL

,	NULL
J.M.M	NULL
.	NULL

Leemans	NULL
,	NULL
W.S	NULL
.	NULL

Bont	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

deVries	NULL
.	NULL

1983	NULL
.	NULL

Theory	NULL
and	NULL
practice	NULL
of	NULL
centrifugal	NULL
elutriation	NULL
(	NULL
CE	NULL
)	NULL
.	NULL

Factors	NULL
influencing	NULL
the	NULL
separation	NULL
of	NULL
human	NULL
blood	NULL
cells	NULL
.	NULL

Cell	NULL
Biophys	NULL
.	NULL

5:105	NULL
.	NULL

Willey	NULL
,	NULL
RL	NULL
.	NULL

1988	NULL
.	NULL

In	NULL
vitro	NULL
mutagenesis	NULL
identifies	NULL
a	NULL
region	NULL
within	NULL
the	NULL
envelope	NULL
gene	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
infectivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:139	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
M.L	NULL
.	NULL

MacKichan	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
has	NULL
lxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
.	NULL

71:243	NULL
.	NULL

Schmitz	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
and	NULL
P.A	NULL
.	NULL

Baeuerle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activation	NULL
potential	NULL
of	NULL
NF-kB	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

10:3805	NULL
.	NULL

Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
E.P	NULL
.	NULL

Dixon	NULL
,	NULL
N.J.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doetrre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
b	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:1875	NULL
.	NULL

Crystal	NULL
,	NULL
R.G	NULL
.	NULL

1990.	NULL
x1-antitrypsin	NULL
deficiency	NULL
,	NULL
emphysema	NULL
,	NULL
and	NULL
liver	NULL
disease	NULL
.	NULL

Genetic	NULL
basis	NULL
and	NULL
strategies	NULL
for	NULL
therapy	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1343	NULL
.	NULL

Chiao	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
S.	NULL
Miyamoto	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Verma	NULL
.	NULL

1994	NULL
.	NULL

Autoregula-tion	NULL
of	NULL
IkBa	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:28.	NULL
deMartin	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Vanhove	NULL
,	NULL
Q.	NULL
Cheng	NULL
,	NULL
E.	NULL
Hofer	NULL
,	NULL
V.	NULL
Csizmadia	NULL
,	NULL
H.	NULL
Winkler	NULL
,	NULL
and	NULL
EH	NULL
.	NULL

Bach	NULL
.	NULL

1993	NULL
.	NULL

Cytokine-inducible	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
of	NULL
an	NULL
IxBa-like	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

12:2773	NULL
.	NULL

Olsson	NULL
,	NULL
I.	NULL
,	NULL
U.	NULL
Gullberg	NULL
,	NULL
and	NULL
M.	NULL
Lantz	NULL
.	NULL

1990	NULL
.	NULL

Cytokine	NULL
and	NULL
non-cytokine	NULL
differentiating	NULL
agents	NULL
for	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
.	NULL

Leukemia	NULL
Res	NULL
.	NULL

14:711	NULL
.	NULL

Takahashi	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Nukiwa	NULL
,	NULL
P.	NULL
Basset	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Crystal	NULL
.	NULL

1988	NULL
.	NULL

Myelomonocytic	NULL
cell	NULL
lineage	NULL
expression	NULL
of	NULL
the	NULL
neutrophil	NULL
elastase	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:2543	NULL
.	NULL

Hanson	NULL
,	NULL
R.D	NULL
.	NULL

,	NULL
N.L	NULL
.	NULL

Connolly	NULL
,	NULL
D.	NULL
Burnett	NULL
,	NULL
E.J	NULL
.	NULL

Campbell	NULL
,	NULL
R.M	NULL
.	NULL

Senior	NULL
,	NULL
and	NULL
T.J.	NULL
Ley	NULL
.	NULL

1990	NULL
.	NULL

Developmental	NULL
regulation	NULL
1455	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66.	NULL
of	NULL
the	NULL
human	NULL
cathepsin	NULL
G	NULL
gene	NULL
in	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:1524.	NULL
Zimmer	NULL
,	NULL
M.	NULL
,	NULL
RL	NULL
.	NULL

Medcalf	NULL
,	NULL
TM	NULL
.	NULL

Fink	NULL
,	NULL
C.	NULL
Mattmann	NULL
,	NULL
P.	NULL
Lichter	NULL
,	NULL
and	NULL
D.E	NULL
.	NULL

Jenne	NULL
.	NULL

1992	NULL
.	NULL

Three	NULL
human	NULL
elastase-like	NULL
genes	NULL
coordinately	NULL
expressed	NULL
in	NULL
the	NULL
myelomonocyte	NULL
lineage	NULL
are	NULL
organized	NULL
as	NULL
a	NULL
single	NULL
genetic	NULL
locus	NULL
on	NULL
19pter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

89:8215	NULL
.	NULL

Gabay	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
and	NULL
RP	NULL
.	NULL

Almeida	NULL
.	NULL

1993	NULL
.	NULL

Antibiotic	NULL
peptides	NULL
and	NULL
serine	NULL
protease	NULL
homologs	NULL
in	NULL
human	NULL
polymorphonuclear	NULL
leu-kocytes	NULL
:	NULL
defensins	NULL
and	NULL
azurocidin	NULL
.	NULL

Cur	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:97	NULL
.	NULL

Campbell	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
EK	NULL
.	NULL

Silverman	NULL
,	NULL
and	NULL
M.A	NULL
.	NULL

Campbell	NULL
.	NULL

1990	NULL
.	NULL

Elastase	NULL
and	NULL
cathepsin	NULL
G	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:2961	NULL
.	NULL

Harris	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
P.	NULL
Ralph	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
leukemic	NULL
models	NULL
of	NULL
myelomonocytic	NULL
development	NULL
:	NULL
a	NULL
review	NULL
of	NULL
the	NULL
HL-60	NULL
and	NULL
U937	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Leuk	NULL
.	NULL

Biol	NULL
.	NULL

37:407	NULL
.	NULL

Welgus	NULL
,	NULL
H.G	NULL
.	NULL

,	NULL
N.L	NULL
.	NULL

Connolly	NULL
,	NULL
and	NULL
R.M	NULL
.	NULL

Senior	NULL
.	NULL

1986	NULL
.	NULL

12-0-tetradecanoyl-phorbol-13-acetate-differentiated	NULL
U937	NULL
cells	NULL
express	NULL
a	NULL
macrophage-like	NULL
profile	NULL
of	NULL
neutral	NULL
proteinases	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
secreted	NULL
collagenase	NULL
and	NULL
collagenase	NULL
inhibitor	NULL
accompany	NULL
low	NULL
levels	NULL
of	NULL
intracellular	NULL
elastase	NULL
and	NULL
cathepsin	NULL
G.	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

77:1675	NULL
.	NULL

Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
B.	NULL
Fernandez	NULL
,	NULL
I.	NULL
Dominguez	NULL
,	NULL
J.M	NULL
.	NULL

Jacque	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
MIT	NULL
.	NULL

Diaz-Meco	NULL
,	NULL
J.	NULL
Moscat	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Virelizier	NULL
,	NULL
1993	NULL
.	NULL

Phosphatidylcholine	NULL
hydrolysis	NULL
activates	NULL
NF-kB	NULL
and	NULL
increases	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:6596	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Beauparlant	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1993	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/Rel	NULL
DNA	NULL
binding	NULL
activities	NULL
in	NULL
my-elomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5235	NULL
.	NULL

Suzan	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Salaun	NULL
,	NULL
C.	NULL
Neuveut	NULL
,	NULL
B.	NULL
Spire	NULL
,	NULL
I.	NULL
Hirsch	NULL
,	NULL
P.	NULL
Le-Bouteiller	NULL
,	NULL
G.	NULL
Querat	NULL
,	NULL
and	NULL
J.	NULL
Sire	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
NF-KB	NULL
during	NULL
monocyte-differentiation	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:377	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
M.	NULL
Brockhaus	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
R.	NULL
Remy	NULL
,	NULL
R.	NULL
Kolbeck	NULL
,	NULL
and	NULL
A.P.G.M	NULL
.	NULL

vanLoon	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
types	NULL
A	NULL
and	NULL
B	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptors	NULL
is	NULL
independently	NULL
regulated	NULL
,	NULL
and	NULL
both	NULL
receptors	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:22409	NULL
.	NULL

Hohmann	NULL
,	NULL
H.-P.	NULL
,	NULL
R.	NULL
Remy	NULL
,	NULL
C.	NULL
Scheidereit	NULL
,	NULL
and	NULL
A.P.G.Mw	NULL
.	NULL

Loon	NULL
.	NULL

1991	NULL
.	NULL

Maintenance	NULL
of	NULL
NF-KB	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
protein	NULL
synthesis	NULL
and	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
external	NULL
stimuli	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:259	NULL
.	NULL

Israel	NULL
,	NULL
N.	NULL
,	NULL
M.-A	NULL
.	NULL

Gougerot-Pocidalo	NULL
,	NULL
F.	NULL
Aillet	NULL
,	NULL
and	NULL
J.-L.	NULL
Virelizier	NULL
.	NULL

1992	NULL
.	NULL

Redox	NULL
status	NULL
of	NULL
cells	NULL
influences	NULL
constitutive	NULL
or	NULL
induced	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
and	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
activity	NULL
in	NULL
human	NULL
T	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3385	NULL
.	NULL

Brach	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
S.	NULL
deVos	NULL
,	NULL
C.	NULL
Arnold	NULL
,	NULL
H.-J	NULL
.	NULL

Grub	NULL
,	NULL
R.	NULL
Mertels-mann	NULL
,	NULL
and	NULL
F.	NULL
Herrmann	NULL
.	NULL

1992	NULL
.	NULL

Leukotriene	NULL
B4	NULL
transcription-ally	NULL
activates	NULL
interleukin-6	NULL
expression	NULL
involving	NULL
NK-	NULL
«	NULL
B	NULL
and	NULL
NF-IL-6	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:2705	NULL
.	NULL

Pomerantz	NULL
,	NULL
R.J.	NULL
,	NULL
M.B	NULL
.	NULL

Feinberg	NULL
,	NULL
D.	NULL
Trono	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Lipopolysaccharide	NULL
is	NULL
a	NULL
potent	NULL
monocyte/macrophage-specific	NULL
stimulatory	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
expression	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:253	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.L	NULL
.	NULL

Kinter	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1994	NULL
.	NULL

Interleukin	NULL
1	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
alone	NULL
and	NULL
in	NULL
synergy	NULL
with	NULL
interleukin	NULL
6	NULL
in	NULL
chronically	NULL
infected	NULL
U1	NULL
cells	NULL
:	NULL
inhibition	NULL
of	NULL
inductive	NULL
effects	NULL
by	NULL
the	NULL
interleukin	NULL
1	NULL
receptor	NULL
antagonist	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

91:108	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
K.L	NULL
.	NULL

Mohn	NULL
,	NULL
D.E	NULL
.	NULL

Cressman	NULL
,	NULL
67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

J.-C.	NULL
Hsu	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
R.	NULL
Taub	NULL
.	NULL

1992	NULL
.	NULL

Rapid	NULL
induction	NULL
in	NULL
regenerating	NULL
liver	NULL
of	NULL
RL	NULL
/IF-1	NULL
(	NULL
an	NULL
l	NULL
«	NULL
B	NULL
that	NULL
inhibits	NULL
NF-KB	NULL
,	NULL
RelB-p50	NULL
,	NULL
and	NULL
c-Rel-p50	NULL
)	NULL
and	NULL
PHF	NULL
,	NULL
a	NULL
novel	NULL
«	NULL
B	NULL
site-binding	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

12:289	NULL
.	NULL

Cappelluti	NULL
,	NULL
E.	NULL
,	NULL
S.C.	NULL
Strom	NULL
,	NULL
and	NULL
R.B	NULL
.	NULL

Harris	NULL
.	NULL

1992	NULL
.	NULL

Potential	NULL
role	NULL
of	NULL
two	NULL
novel	NULL
elastase-like	NULL
enzymes	NULL
in	NULL
processing	NULL
pro-transforming	NULL
growth	NULL
factor-alpha	NULL
.	NULL

Biochemistry	NULL
.	NULL

32:551	NULL
.	NULL

Barrett	NULL
,	NULL
A.J	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
lysosome	NULL
and	NULL
its	NULL
membrane	NULL
.	NULL

Biockem	NULL
.	NULL

Soc	NULL
.	NULL

Trans	NULL
,	NULL
12:899	NULL
.	NULL

Jones	NULL
,	NULL
E.A	NULL
.	NULL

,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Summerfield	NULL
.	NULL

1988	NULL
.	NULL

Kupffer	NULL
cells	NULL
.	NULL

In	NULL
The	NULL
Liver	NULL
:	NULL
Biology	NULL
and	NULL
Pathobiology	NULL
.	NULL

L.	NULL
M.	NULL
Arias	NULL
,	NULL
W.B	NULL
.	NULL

Jakoby	NULL
,	NULL
H.	NULL
Popper	NULL
,	NULL
D.	NULL
Schacter	NULL
,	NULL
and	NULL
D.A	NULL
.	NULL

Shafritz	NULL
,	NULL
editors	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Ltd.	NULL
New	NULL
York	NULL
.	NULL

683-704	NULL
.	NULL

Riess	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Jochum	NULL
,	NULL
W.	NULL
Machleidt	NULL
,	NULL
G.	NULL
Himmelreich	NULL
,	NULL
G.	NULL
Blumhardt	NULL
,	NULL
R.	NULL
Roissanit	NULL
,	NULL
and	NULL
P.	NULL
Neuhaus	NULL
.	NULL

1991	NULL
.	NULL

Possible	NULL
role	NULL
of	NULL
extracellularly	NULL
released	NULL
phagocyte	NULL
proteinases	NULL
in	NULL
coagulation	NULL
disorder	NULL
during	NULL
liver	NULL
transplantation	NULL
.	NULL

Transplantation	NULL
(	NULL
Baltimore	NULL
)	NULL
.	NULL

52:482	NULL
.	NULL

Hamazaki	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Minura	NULL
,	NULL
M.	NULL
Kato	NULL
,	NULL
K.	NULL
Okamoto	NULL
,	NULL
M.	NULL
Yunoki	NULL
,	NULL
M.	NULL
Mori	NULL
,	NULL
K.	NULL
Orita	NULL
,	NULL
and	NULL
N.J.	NULL
Lygidakis	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
post-hepatectomy	NULL
changes	NULL
in	NULL
polymorphonuclear	NULL
elastase	NULL
and	NULL
endotoxin	NULL
levels	NULL
.	NULL

Hepato-Gastroenterology	NULL
.	NULL

40:352	NULL
.	NULL

Bainton	NULL
,	NULL
D.F	NULL
.	NULL

,	NULL
J.L	NULL
.	NULL

Ullyot	NULL
,	NULL
and	NULL
M.G	NULL
.	NULL

Farquhar	NULL
.	NULL

1971	NULL
.	NULL

The	NULL
de-	NULL
1456	NULL
73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77.	NULL
velopment	NULL
of	NULL
neutrophilic	NULL
polymorphonuclear	NULL
leukocytes	NULL
in	NULL
human	NULL
bone	NULL
marrow	NULL
:	NULL
origin	NULL
and	NULL
content	NULL
of	NULL
azurophil	NULL
and	NULL
specific	NULL
granules	NULL
.	NULL

J.	NULL
Exp	NULL
Med	NULL
.	NULL

134:907	NULL
.	NULL

Spitznagel	NULL
,	NULL
J.K.	NULL
1990	NULL
.	NULL

Antibiotic	NULL
proteins	NULL
of	NULL
human	NULL
neutro-phils	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

86:1381	NULL
.	NULL

Yoshimura	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Crystal	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
and	NULL
posttranscriptional	NULL
modulation	NULL
of	NULL
human	NULL
neutrophil	NULL
elastase	NULL
gene	NULL
expression	NULL
.	NULL

Blood	NULL
.	NULL

79:2733	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.L	NULL
.	NULL

Kinter	NULL
,	NULL
J.S	NULL
.	NULL

Justement	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
D.	NULL
Weissman	NULL
,	NULL
L.	NULL
M.	NULL
Fox	NULL
,	NULL
D.	NULL
Goletti	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
S.K	NULL
.	NULL

Stanley	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
chronically	NULL
infected	NULL
promonocytic	NULL
cell	NULL
lie	NULL
U1	NULL
:	NULL
a	NULL
model	NULL
of	NULL
HIV	NULL
expression	NULL
regulated	NULL
by	NULL
cytokines	NULL
.	NULL

Immunomethods	NULL
.	NULL

3:50	NULL
.	NULL

Biswas	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
A.L	NULL
.	NULL

Kinter	NULL
,	NULL
J.S	NULL
.	NULL

Justement	NULL
,	NULL
SK	NULL
.	NULL

Stanley	NULL
,	NULL
W.J	NULL
.	NULL

Maury	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
J.M	NULL
.	NULL

Orenstein	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1992	NULL
.	NULL

Interferon-y	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
persistently	NULL
infected	NULL
promonocytic	NULL
cells	NULL
(	NULL
U1	NULL
)	NULL
and	NULL
redirects	NULL
the	NULL
production	NULL
of	NULL
virons	NULL
to	NULL
intracytoplasmic	NULL
vacuoles	NULL
in	NULL
phorbol	NULL
myristate	NULL
acetate-differentiated	NULL
U1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:739	NULL
.	NULL

Bressler	NULL
,	NULL
P.	NULL
,	NULL
G.	NULL
Poli	NULL
,	NULL
J.S	NULL
.	NULL

Justement	NULL
,	NULL
P.	NULL
Biswas	NULL
,	NULL
and	NULL
A.S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

Glucocorticoids	NULL
synergize	NULL
with	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
HIV	NULL
expression	NULL
from	NULL
a	NULL
chronically	NULL
infected	NULL
promonocytic	NULL
cell	NULL
line	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retro	NULL
.	NULL

9:547	NULL
.	NULL

In	NULL
Vitro	NULL
Proteolysis	NULL
of	NULL
NF-	NULL
«	NULL
B/p65	NULL
in	NULL
HIV	NULL
Replication-impaired	NULL
Cells	NULL

